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Abstract 
The increasing incidence of autism suggests a major environmental influence.  Epidemiology 
has implicated many candidates and genetics many susceptibility genes. Gene/environment 
interactions in autism were analysed using 206 autism susceptibility genes (ASG’s) from the 
Autworks database to interrogate ~1 million chemical/gene interactions in the comparative 
toxicogenomics database. Any bias towards ASG’s was statistically determined for each 
chemical. Many suspect compounds identified in epidemiology, including 
tetrachlorodibenzodioxin, pesticides, particulate matter, benzo(a)pyrene , heavy metals, 
valproate, acetaminophen, SSRI’s, cocaine, bisphenol A, phthalates, polyhalogenated 
biphenyls, flame retardants, diesel constituents , terbutaline and oxytocin, inter alia showed a 
significant degree of bias towards ASG’s, as did relevant endogenous agents (retinoids, sex 
steroids, thyroxine, melatonin, folate, dopamine, serotonin). Numerous other suspected 
endocrine disruptors (over 100) selectively targeted ASG’s including paraquat, atrazine and 
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other pesticides not yet studied in autism and many compounds used in food, cosmetics or 
household products, including tretinoin, soy phytoestrogens , aspartame, titanium dioxide and 
sodium fluoride. Autism polymorphisms influence the sensitivity to some of these chemicals 
and these same genes play an important role in barrier function and control of respiratory 
cilia sweeping particulate matter from the airways. Pesticides, heavy metals and pollutants 
also disrupt barrier and/or ciliary function, which is regulated by sex steroids and by 
bitter/sweet taste receptors. Further epidemiological studies and neurodevelopmental and 
behavioural research is warranted to determine the relevance of large number of suspect 
candidates whose addition to the environment, household, food and cosmetics might be 
fuelling the autism epidemic in a gene-dependent manner.  
Key words: Autism; gene/environment; pesticides, heavy metals, pollutants; pregnancy 
Introduction 
According to the Center for disease control (CDC) 
http://www.cdc.gov/ncbddd/autism/data.html the USA incidence of autism spectrum 
disorders rose 2.2 fold from 2000  to 2010  [1]. In the UK, a five-fold increase in autism in 
the 1990’s , reached a plateau in the 2000’s up to 2010 [2]. This increased prevalence is 
likely partly due to environmental influences, of which there are many candidates.  Many 
chemical classes or specific chemicals related to autism have been reviewed by Rossignol or 
Sealey and co-authors [3,4]. These include pesticides, heavy metals, diesel, particulate 
matter,   and other traffic and air or smoking  pollutants, as well as Bisphenol A, phthalates , 
solvents and polychlorinated or polybrominated biphenyls found in household objects such as 
feeding bottles, fragrances or flame retardants.  Certain drugs used in pregnancy, including 
valproate, selective serotonin reuptake inhibitor antidepressants (SSRI’s), acetaminophen, 
dexamethasone, terbutaline oxytocin and prostaglandins have also been linked to the 
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development of autism. These and other environmental risk factors are referenced in Table 1, 
which also includes details of animal studies related to autism, where available. Evidently 
certain compounds have been more extensively studied and further work is needed for many.  
It should also be appreciated that, as in genetic studies, replication is a problem in 
epidemiology, but also that gene/environment interactions may partly explain some 
disparities (i.e. compound X affects autism if it influences, or is influenced by susceptibility 
gene(s) products Y, Z etc., or gene Y shows association only if compound X is relevant). This 
is exemplified for paraoxonase 1 (PON1) variants, which metabolise organophosphate 
pesticides. PON1 is associated with autism in US studies, where organophosphate use is 
extensive, but not in Italy where organophosphate use is low [5].  
Autism related genes are preferentially expressed prenatally in the frontal cortex suggesting 
that an inherent genetic susceptibility may be confined to this period [6] . Many of these 
compounds are endocrine disruptors which have been linked to a variety of diseases, 
including autism, attention hyperactivity deficit disorder, obesity and diabetes, whose 
incidence has increased in recent decades. Their annual burden of health cost in the European 
Union has been estimated at over 100 billion Euros [7,8] . 
A number of compounds detailed in Table 1, or related compounds have also been shown to 
produce autism-relevant behavioural effects in laboratory models when administered 
prenatally, although not all have been studied. These include pesticides, fungicides  or 
herbicides (atrazine, chlorpyrifos, cypermethrin, the DDT metabolite 
Dichlorodiphenyldichloroethylene (DDE), endosulfan,  linuron, prochloraz, procymidone, . 
tetrachlorodibenzodioxin and vinclozolin)  heavy metals (aluminium, cadmium, lead, 
arsenate, manganese, or mercury)  bisphenol A and phthalates and other pollutants  
(perfluorooctanoic acid, 4-methylbenzylidene camphor, 2-ethylhexyl 4-methoxycinnamate, 
butylparaben, polychlorinated and polybrominated biphenyls (flame retardants) and 
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particulate matter) as well as dexamethasone, fluoxetine, terbutaline, thalidomide and 
valproic acid .Others such as  Rotenone and fungicides (pyraclostrobin, trifloxystrobin, 
famoxadone or fenamidone) as well as fluoxetine, carbamazepine and venlafaxine, or 
valproate also produce transcriptome changes consistent with autism (See Table 1 for 
references). 
Genes associated with autism are catalogued at the Autworks database using a confidence 
score  derived from analysis of the Genotator association database [9,10] . 206 genes are 
regarded as prime autism susceptibility candidates and these genes and network analyses are 
available at the autworks site from the Wall lab at Harvard University 
http://tools.autworks.hms.harvard.edu/gene_sets/580/genes .   
This same set of genes has recently been shown to be localised and enriched in many barriers 
including the blood brain barrier, as well as skin, intestinal, placental and trophoblast barriers. 
Several also play an important role in relation to respiratory cilia that sweep noxious particles 
from the airways. These barrier-related genes are thus in a position to modify the access of 
numerous environmental agents to the blood and brain and their role in respiratory cilia is 
relevant to particulate matter and airborne pollutants [11].   
Given the strength of the various environmental associations with autism, and its increasing 
prevalence over recent years, it is possible that the environmental influences that target these 
genes may afford clues as to the combined and conditional causes of autism.  
Epigenetic changes have been observed in autism, and these too may be related to 
environmental agents [12,13] as reported for Bisphenol A and heavy metals (see Table 1) and 
for flame retardants and other endocrine disruptors, including soy formula and 
phytoestrogens such as genistein  [14-16] and also for other nutritional agents such as 
Vitamin D and folic acid[17-19]. However, epigenetics is not the subject of this study, which 
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is limited to the 206 autism-related polymorphic genes reported from gene association 
studies.   
Chemical influences on the 206 Autworks susceptibility genes (ASG’s) were analysed using 
the Comparative Toxicogenomics Database (CTD) [20]  which records over 1 million 
interactions between diverse chemicals and genes or proteins. Previous work using this 
database has already shown a link between autism or other disease-related genes and 
environmental risk factors [21]. For example, asthma has been linked with p,p'-DDT, and 
autism with o,p'-DDT, both metabolites of the organochlorine insecticide 
dichlorodiphenyltrichloroethane (DDT)[22]. 
 The results suggest that the toxicogenomic effects of many chemicals associated with autism 
selectively target the ASG’s, showing a close relationship between genes and environment. 
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Table 1 
Compounds that have been implicated in autism in epidemiological studies, or where 
different blood, hair or tissue levels have been reported. Where available, relevant animal 
studies are also noted. 
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Herbicides  Human studies Animal studies  
2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD : Agent orange defoliant 
contaminant) 
Breast milk 
concentrations 
associated with autism 
in 3 year old 
Vietnamese children  
[23]. Dioxin toxicity, 
including TCDD, also 
related to autism and 
neurodevelopmental 
problems in a follow-up 
Vietnamese study. [24]  
Dioxin and 
polychlorinated 
biphenyl maternal  
blood levels also related 
to autistic traits in a 
German study [25].     
polychlorinated 
dibenzo-p-dioxin 
exposure during the 
brain growth spurt — 
extending from the third 
trimester of pregnancy 
to age 2 related to 
autism: Reviewed in [3] 
relatively low doses of four  
endocrine disruptors , 
atrazine (10mg/kg), 
perfluorooctanoic acid 
(0.1mg/kg), bisphenol-A 
(50 µg/kg), 2,3,7,8-
tetrachlorodibenzo-p-dioxin 
(0.25 µg/kg) alone or 
combined in a mixture, 
from gestational day 7 until 
weaning produce 
behavioural toxicity , which 
for mixture effects was 
predominantly seen in male 
mice offspring [26]. 
 
Pesticides At sub-cytotoxic concentrations, Rotenone and 
fungicides (pyraclostrobin, trifloxystrobin, 
famoxadone or fenamidone) produce transcriptional 
changes in mouse cortical cultures in vitro that are 
similar to those seen in brain samples from humans 
with autism, ageing or neurodegeneration (Alzheimer's 
disease and Huntington's disease)[27]. 
Residential proximity to acephate and oxydemeton-
methyl and pyrethroids, neonicotinoids, and 
manganese fungicides linked to poorer 
neurodevelopment in children ( Center for the Health 
Assessment of Mothers and Children Of Salinas 
(CHAMACOS) study).  [28] 
Dichlorodiphenyltrichloroethane 
(DDT) 
metabolite  
metabolite: 
Dichlorodiphenyldichloroethylene = 
(DDE) 
Farm families exposed 
to pesticides show an 
increased  autism 
incidence : Reviewed in 
[3] 
High doses of endocrine 
disrupting mixtures, (di-n-
butylphthalate, 
diethylhexylphthalate, 
vinclozolin, prochloraz, 
procymidone, linuron, 
epoxiconazole, and DDE) 
or  (bisphenol A, 4-
methylbenzylidene 
camphor, 2-ethylhexyl 4-
methoxycinnamate, and 
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butylparaben), when 
administered prenatally to 
rats have been shown to 
modify the expression of 
genes related to 
glutamatergic function, the 
migration and pathfinding 
of GABAergic and 
glutamatergic neurones and 
of autism-related genes in 
the offspring [29].      
Dicofol (Organochlorine) Exposure during 
pregnancy linked to 
autism in the offspring: 
Reviewed in [3] 
None found 
Endosulfan (Organochlorine) Exposure during 
pregnancy associated 
with autism : Reviewed 
in [3] 
Endosulfan or cypermethrin 
( (0.1 or 0.5mg/kg) 
administered orally to 10 
day old mice subsequently 
altered the levels of brain 
protein relevant to brain 
development, and produced 
neurobehavioral 
abnormalities manifested as 
altered adult spontaneous 
behaviour and ability to 
habituate to a novel home 
environment. These effects 
persisted for several months 
[30]. Supported by in vitro 
and in vivo studies in mice 
showing deleterious effects 
on pre and postsynaptic 
dopamine,GABA and 
glutamate function in the 
frontal cortex  [31] 
Chlordan (Organochlorine mix of 
cis- and trans nonachlor) 
Maternal blood or urine 
sample levels of trans-
nonachlor associated 
with subsequent 
childhood autistic 
behaviour  (Health 
Outcomes and 
Measures of the 
Environment) Study 
(Cincinnati, Ohio) [32] 
None found 
Chlorpyrifos  Umbilical cord plasma 
levels  linked to autism 
in the offspring:  
Reviewed in [3]. 
Chlorpyrifos ( on 
gestational days 14-17 at 
the sub-toxic dose of 6 
mg/kg) induces relevant 
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Proximity to 
organophosphates at 
some point during 
gestation was associated 
with a 60% increased 
risk for autism, which 
was higher for third-
trimester exposures or 
second-trimester 
chlorpyrifos application 
[33]. 
behavioural effects in mice 
offspring when 
administered during 
pregnancy , showing male 
preference and [34] 
increases brain markers of 
oxidative stress in the 
offspring  in a  strain (gene) 
- and age-dependent manner 
[34-36] 
Organophosphates and pyrethroids This study linked 
combined rather than 
individual exposure to 
diverse pesticides, 
globally showing 
association with autism 
[33].  The most 
abundant of which was 
chlorpyrifos (20.7%), 
followed by acephate 
(15.4%), and diazinon 
(14.5%). Of the 
pyrethroids, one-quarter 
of the total was 
esfenvalerate (24%), 
followed by lamda-
cyhalothrin (17.3%), 
permethrin (16.5%), 
cypermethrin (12.8%), 
and tau-fluvalinate 
(10.5%). Of the 
carbamates, 
approximately 80% 
were methomyl or 
carbaryl, and of the 
organochlorines, 60% 
of all applications were 
dienochlor. 
Paraoxonase (PON1) 
variants associated with 
autism are less able to 
metabolise diazinon [5]’ 
High urinary 
concentrations of the 
pyrethroid metabolite,  
3-Phenoxybenzoic acid,  
observed in autistic 
children [37].). 
(For cypomethrin, See 
endosulfan above) 
Heavy metals  Gestational exposure to 
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heavy metals in drinking 
water, from the first day of 
pregnancy to day 10.5 
(cadmium, 10 parts per 
million (ppm); lead, 
300 ppm; arsenate, 0.5 ppm; 
manganese, 10 ppm;  
mercury, 20ppm) or 
valproic acid (600 mg/kg 
i.p. on gestational day 8.5 
produces multiple 
behavioural , 
neurodevelopmental-related 
abnormalities that persist 
into adulthood in male mice 
offspring , effects that are 
accompanied by epigenetic 
changes in gene 
methylation [38] 
Aluminium  Elevated hair 
concentrations of 
aluminium, arsenic, 
cadmium, mercury, 
antimony, nickel, lead, 
and vanadium observed 
in autistic children 
[39].Aluminium 
concentrations also 
elevated in urine 
samples [40]. Autism 
incidence correlated 
with the use of 
aluminium adjuvants in 
vaccines across several 
countries [41]. The use 
of polybrominated 
diphenyl ethers, 
aluminium adjuvants, 
and the herbicide 
glyphosate have 
increasing trends that 
correlate positively to 
the rise in autism (not 
the case for lead, 
organochlorine 
pesticides or vehicular 
emissions)[42]. 
The prenatal administration 
of aluminium to mice in 
“vaccine-relevant amounts” 
produces weight gain and 
reduced exploratory activity 
in the light/dark test box in 
male and female adults (6 
months) and reduced open-
field activity in male mice 
[43].  
Antimony High hair levels found 
in autistic children 
[39,44] 
None found 
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Arsenic Autism prevalence 
linked to proximity to 
industrial facilities 
releasing arsenic, lead 
or mercury [45].  high 
levels of mercury, lead, 
arsenic, antimony and 
cadmium in hair 
samples of autistic 
children [44] 
See heavy metals and 
epigenetic effects  (above) 
[38] 
Cadmium Retrospective air levels 
in  birth areas related to 
autism in 2 year old 
children:  Reviewed in 
[3] 
See heavy metals and 
epigenetic effects  (above) 
[38] 
Chromium Living in areas with 
higher air levels of 
styrene and chromium 
during pregnancy 
associated with 
increased autism risk ( 
National Air Toxics 
Assessment , 
Pennsylvania USA [46]:   
Higher urinary 
Chromium  levels in 
children with autism 
(Turkish study)[47] 
None found 
Copper High serum copper 
levels in autistic 
children and/or low 
Zn/Cu ratio observed in 
several studies [48-51] 
Increased copper levels lead 
to local zinc deficiencies in 
mice.  Prenatal copper 
overload reduces 
ProSAP/Shank protein 
levels in the brain and 
decreases the expression of 
the N-methyl-D-aspartate 
receptor subunit (GRIN1), 
thus influencing a pathway 
in excitatory synapses 
associated with autism [52] 
Iron Low prenatal iron levels 
associated with autism 
[53]: Low iron levels 
also observed in autistic 
children [54,55]  
Adult offspring from iron-
deficient rat dams show 
deficits in pre-pulse 
inhibition of acoustic startle 
and in passive avoidance 
learning [56] . 
Lead Birth residence air 
levels associated with 
autism : Reviewed in 
[3]. Data from 4486 
See heavy metals (above) 
[38] 
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autistic children 
residing in 2489 census 
tracts in five sites of the 
Centers for Disease 
Control and 
Prevention's Autism and 
Developmental 
Disabilities Monitoring 
Network showed a 
potential link between 
ambient lead 
concentrations and 
autism prevalence and 
that exposure to 
multiple metals (lead, 
arsenic mercury) may 
have synergistic effects 
on autism 
prevalence[57]. 
Manganese  Perinatal exposure to 
lead, manganese, 
mercury, nickel, diesel 
particulate, methylene 
chloride, and the overall 
metal score associated 
with autism [58] 
Birth residence air 
levels of manganese 
chloride  associated 
with autism  Reviewed 
in [3].  poorer 
neurodevelopment in 
children linked to 
manganese-containing 
fungicides[28]. A 
synergistic effect of 
blood manganese 
concentrations and  
glutathione transferase 
(GSTP1) 
polymorphisms has 
been observed in 
relation to autism risk 
[59]  
See heavy metals (above) 
[38] 
Mercury Birth residence air 
levels associated with 
autism: Reviewed in [3] 
See heavy metals (above) 
[38] 
Molybdenum High hair levels found 
in autistic children 
[39,44] 
None found 
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Nickel High birth residence air 
levels: Reviewed in [3]:  
In four studies, weak 
associations were found 
for nickel and autism 
spectrum disorder 
(Review) [60].  
None found 
Tin Higher urinary levels of 
lead, thallium, tin , and 
tungsten in autistic 
children [61] 
None found 
Tungsten  Higher urinary levels of 
lead, thallium, tin , and 
tungsten in autistic 
children [61] 
None found 
Vanadium Elevated hair 
concentrations of 
aluminium, arsenic, 
cadmium, mercury, 
antimony, nickel, lead, 
and vanadium observed 
in autistic children [39] 
None found 
Zinc  Zinc deficiency and 
copper excess and/or 
low Zn/Cu ratio have 
been observed in autism 
in several studies  [48-
51,62-64]   
Prenatal zinc 
supplementation attenuates 
autistic-like behaviour in 
animal models of autism 
[65,66] 
Air Pollution   
1,3-butadiene  Exposure during 
pregnancy associated 
with autism [67]  
None found 
Carbon monoxide Exposure in children 
during previous 4 years 
linked to autism : 
Reviewed in [3] 
None found 
Diesel particulate and diesel Birth residence air 
levels linked to autism: 
Reviewed in [3]. 
Perinatal exposure to 
diesel has been 
associated with autism, 
particularly in male 
children [58]. 
 Exposure to diesel exhaust 
particles during pregnancy 
and nursing in mice 
increases locomotor activity 
and repetitive behaviours in 
the offspring, which did not 
show deficits in social 
interactions or social 
communication [68].  Mice 
acutely exposed to diesel 
exhaust (250-300μg/m3 for 
6h) show microglia 
activation, increased lipid 
peroxidation, and neuro-
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inflammation, particularly 
in the hippocampus and the 
olfactory bulb. Adult 
neurogenesis was also 
impaired. In most cases, the 
effects of were more 
pronounced in male mice 
[69]. 
Formaldehyde Exposure during 
pregnancy associated 
with autism [67] 
None found 
Methylene chloride Birth residence air 
levels linked to autism : 
Reviewed in [3] and 
[70] 
None found 
Nicotine (smoking) ADHD symptoms and 
autistic traits scores 
have been associated 
with elevated levels of 
regular smoking; 
cannabis use; and 
nicotine, alcohol, and 
cannabis use disorders 
[71] . Perinatal or 
prenatal smoking has 
been associated with 
autism [72-75], 
although in adulthood, 
lower smoking levels 
have been observed in 
adulthood [76]  
None found 
Nitric oxide Air pollution linked to 
autism incidence [77] 
None found 
Nitrogen dioxide (NO2) Birth residence air 
levels  linked to autism: 
Reviewed in [3].  NO2 
levels during gestation 
or during the first year 
of life related to autism 
[78] .  Child exposure to 
Ozone, carbon 
monoxide,  NO2, and  
SO2 in the preceding 1 
year to 4 years increases 
the risk of diagnosis for 
autism spectrum 
disorders (Taiwan) [79] 
None found 
Nitrous oxide (N2O) ? A review has shown that 
exposure to N2O, even at 
non-toxic doses, can  
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modulate central 
neurotransmission and 
targets many neural 
substrates directly 
implicated in 
neurodevelopmental 
disorders, including the 
glutamatergic, opiate, 
cholinergic, and 
dopaminergic systems [80]. 
Ozone Exposure in children 
during previous 4 years 
associated with autism : 
Reviewed in [3] Child 
exposure to Ozone, 
carbon monoxide,  NO2, 
and  SO2 in the 
preceding 1 year to 4 
years increases the risk 
of diagnosis for autism 
spectrum disorders 
(Taiwan) [79] 
None found 
particulate matter <2.5 μm (PM2.5) 
particulate matter <10 μm (PM10) 
 
There appears to be a divergence 
between North American and 
European studies (perhaps related to 
different levels/types of pollution?) 
Birth residence air 
levels linked to autism: 
Reviewed in [3].Meta-
analysis: PM2.5 and 
NO2 exposure during 
pregnancy associated 
with increased risk of 
autism. Ozone exposure 
during the third 
trimester also weakly 
associated (Canada) 
[81].  Prenatal and 
postnatal exposures to 
PM2.5 and to a lesser 
extent nitrogen oxides 
are associated with 
increased risk of autism 
(literature review) [82].  
Higher maternal 
exposure to PM2.5 
during pregnancy, 
particularly the third 
trimester associated 
with greater risk of a 
child with autism 
spectrum disorder 
(USA) [83]: Also seen 
for PM10 in the third 
Lateral ventricular 
dilatation observed in 
young male mice exposed 
to ultrafine particles 
(<100nm) (a phenomenon 
also seen in autism and 
schizophrenia). Glial 
activation was also 
observed  [88].  Such 
exposure also induced 
inflammation/microglial 
activation, reductions in 
size of the corpus callosum 
(CC) and associated 
hypomyelination, aberrant 
white matter development 
and/or structural integrity 
with ventriculomegaly 
(VM), elevated glutamate 
and excitatory/inhibitory 
imbalance, increased 
amygdala astrocytic 
activation, and repetitive 
and impulsive behaviours 
[89]. 
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trimester (USA) [84].  
PM2.5 and PM10 also 
associated with autism 
during gestation (USA) 
[78]. Ozone and PM 2.5 
air levels as well as 
nitric oxide and 
nitrogen dioxide in area 
of birth residence 
related to autism (USA) 
[77].  The effects of air 
pollution may be gene-
dependent: the MET 
receptor tyrosine kinase 
rs1858830 CC genotype 
and air pollutant 
exposure may interact 
to increase the risk of 
autism spectrum 
disorder(USA) [85] . 
 
Early life exposure to 
low levels of nitrous 
oxides or PM10 from 
road traffic does not 
appear to increase the 
risk of autism spectrum 
disorders  (Swedish 
study and a large 
European study 
)[86,87]. 
 
Quinoline  Birth residence air 
levels  linked to autism: 
Reviewed in [3] 
None found 
Smoking Several, but not all 
studies have implicated 
prenatal or perinatal 
parental smoking with 
autism in children 
[72,73,90-94].  
Maternal passive 
smoking during 
pregnancy has been 
associated with 
children’s autistic 
behaviour [95] 
None found 
Styrene  Birth residence air 
levels associated with 
autism: Reviewed in [3] 
None found 
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and [70]. Living in 
areas with higher air 
levels of styrene and 
chromium during 
pregnancy associated 
with increased autism 
risk [46] 
Sulphur dioxide SO2 Exposure in children 
during previous 4 years 
linked to autism: 
Reviewed in [3]:  Child 
exposure to Ozone, 
carbon monoxide,  NO2, 
and  SO2 in the 
preceding 1 year to 4 
years increases the risk 
of diagnosis for autism 
spectrum disorders 
(Taiwan) [79] 
None found 
Trichloroethylene Retrospective air levels 
in birth areas associated 
with autism in 2 year 
old children:  Reviewed 
in [3] and [70] 
None found 
Vinyl Chloride Retrospective air levels 
in birth areas related to 
2 year old autistic 
children:  Reviewed in 
[3] 
None found 
Parental occupational exposure 
Xylene  Reviewed in [3]. In a 
study relating risks for 
autism in children 
related to in utero 
exposure to monitored 
ambient air toxins from 
urban emissions in Los 
Angeles county , autism 
incidence was increased 
in relation to  1,3-
butadiene, meta/para-
xylene , other aromatic 
solvents, lead,  
perchloroethylene, and 
formaldehyde [67].  
Exposure to lacquer, 
varnish, and xylene 
occurred more often in 
the parents of children 
with ASD compared to 
None found 
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the parents of 
unaffected children 
(CHARGE study) [96]. 
Others   
Bisphenol A  Exposure during the 
brain growth spurt — 
extending from the third 
trimester of pregnancy 
to age 2 linked to 
autism  Reviewed in 
[3]. Higher bisphenol A 
and metabolite urine 
levels also reported in 
autistic children [97]. 
Children with autism 
spectrum disorder had 
significantly increased 
serum mono-(2-
ethylhexyl)-phthalate , 
di-(2-ethylhexyl)-
phthalate , and 
bisphenol A  
concentrations 
compared to healthy 
control subjects [98] 
Following gestational 
exposure to BPA (400-
μg/kg ) in rats,  male but not 
female offspring  had 
increased numbers of 
neurons and glia in layers 
5/6 of the medial prefrontal 
cortex in adulthood [99]. 
BPA exposure during 
gestation has long lasting, 
transgenerational effects 
(epigenetic) on social 
recognition and activity in 
mice.  Brains from embryos 
(embryonic d 18.5) exposed 
to BPA had lower gene 
transcript levels for 
estrogen receptors, 
oxytocin, and vasopressin. 
The effects on vasopressin 
expression persisted into the 
fourth generation, at which 
time oxytocin was also 
reduced but only in males 
[100-102]. 
Perchlorate Levels in drinking water 
linked to autism: 
Reviewed in [3] 
None found 
Phthalates Exposure during 
pregnancy related to 
autism: Reviewed in 
[3]’ PVC flooring ( a 
source of airborne 
phthalates)  in parent’s 
bedroom associated 
with childhood autism 
[103]. 
Children with autism 
spectrum disorder had 
significantly increased 
serum mono-(2-
ethylhexyl)-phthalate , 
di-(2-ethylhexyl)-
phthalate , and 
bisphenol A  
concentrations 
Endocrine disrupting 
mixtures, (di-n-
butylphthalate, 
diethylhexylphthalate, 
vinclozolin, prochloraz, 
procymidone, linuron, 
epoxiconazole, and DDE) 
or  (bisphenol A, 4-
methylbenzylidene 
camphor, 2-ethylhexyl 4-
methoxycinnamate, and 
butylparaben), when 
administered prenatally to 
rats have been shown to 
modify the expression of 
genes related to 
glutamatergic function, the 
migration and pathfinding 
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compared to healthy 
control subjects [98] 
of GABAergic and 
glutamatergic neurones and 
of autism-related genes in 
the offspring [29].      
Diethyl phthalate and Di-
butylphthalate 
Among autism and 
development delay 
boys, higher indoor dust 
concentrations of were 
associated with greater 
hyperactivity-
impulsivity and 
inattention [104]. 
[di-(2-ethylhexyl) phthalate 
metabolites: (5-OH-MEHP [mono-
(2-ethyl-5-hydroxyhexyl) 1,2-
benzenedicarboxylate] and 5-oxo-
MEHP [mono-(2-ethyl-5-oxohexyl) 
1,2-benzenedicarboxylate) 
Higher urinary 
concentrations in 
autistic children [105]. 
Decreased Diethylhexyl 
Phthalate 
glucuronidation in 
autistic children [106]. 
Polychlorinated biphenyls (PCB) Exposure during the 
brain growth spurt — 
extending from the third 
trimester of pregnancy 
to age 2 related to 
autism Reviewed in [3]. 
High serum levels of 
PCB’s in banked 
second trimester 
maternal samples 
associated with an 
increased risk of autism 
(particularly so for 
PCB138/158 and 
PCB153 ) [107]. 
Polychlorinated biphenyl 
perinatally exposed rats 
show significantly impaired 
social recognition as 
indicated by persistent 
conspecific-directed 
exploration by juvenile 
animals regardless of social 
experience [108].  PCB-95 
(2,2',3,5'6-
pentachlorobiphenyl) 
induces dendritic growth  in 
primary rat hippocampal 
neurons [109]. 4-OH-
2',3,4',5,6'-
pentachlorobiphenyl and 
bisphenol A  inhibit the 
thyroid hormone-dependent 
dendritic development of 
Purkinje cells. 4-OH-
2',3,3',5',6'-
pentachlorobiphenyl, 4-OH-
2',3,3',5,5',6'-
hexachlorobiphenyl, 4-OH-
2,2',3,4',5,5',6-
heptachlorobiphenyl, 
progesterone and 
nonylphenol promoted the 
dendritic extension of 
Purkinje cells in the absence 
of thyroid hormone [110]. 
Polybrominated diphenyls (flame 
retardants) 
polybrominated 
diphenyl ether-28 
Global hypomethylation of 
adult brain DNA was 
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 (Flame retardants) (PBDE-28) or trans-
nonachlor maternal 
blood or urine sample 
levels associated with 
subsequent childhood 
autistic behaviour [32].  
Exposure during the 
brain growth spurt — 
extending from the third 
trimester of pregnancy 
to age 2 has been 
associated with autism 
(Reviewed in [3]).  The 
use of polybrominated 
diphenyl ethers, 
aluminium adjuvants, 
and the herbicide 
glyphosate have 
increasing trends that 
correlate positively to 
the rise in autism (not 
the case for lead, 
organochlorine 
pesticides or vehicular 
emissions)[42] 
observed in female 
offspring perinatally 
exposed to low 
concentrations of  2,2',4,4'-
tetrabromodiphenyl ether 47 
(BDE47) which coincided 
with reduced sociability 
(study in mutant MECP2 
dams) [111]. BDE49  ( 
2,2',4,5'-tetrabromodiphenyl 
ether ) also inhibits 
mitochondrial electron 
transport at Complex IV 
and V at nanomolar 
concentrations in  brain 
mitochondria and in 
neuronal progenitor striatal 
cells [112]    
Soy infant formula  Data from the Simons 
Foundation Autism 
Research Initiative 
Simplex Collection 
(1949 children) 
suggested an 
association between the 
use of Soy infant 
formula and certain 
behavioural aspects of 
autism [113]  
None found 
Benzo(a)pyrene (Polycyclic 
aromatic hydrocarbon) 
Impacts cognitive development in children who have 
been exposed in utero and impairs learning in animal 
models [114] 
Drugs used in pregnancy or to 
induce or delay labour. 
  
Acetaminophen (paracetamol) Maternal use during 
pregnancy and in 
perinatal periods 
associated with autism 
in the offspring [115]: 
Use after measles-
mumps-rubella 
vaccination also 
associated with autism 
None found 
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in  children of 5 years 
of age or less [116].   
Prenatal acetaminophen 
exposure was associated 
with a greater number 
of autism spectrum 
symptoms in males and 
showed adverse effects 
on attention-related 
outcomes in male and 
female children. 
(Spanish birth cohort 
study including 2644 
mother-child pairs 
recruited during 
pregnancy)[117]. 
Antibiotics Maternal influenza 
infection was associated 
with or prolonged 
episodes of fever 
increased the risk of 
infantile autism. The 
use of various 
antibiotics during 
pregnancy was a 
potential, but relatively 
weak risk factor for 
Autism spectrum 
disorders/infantile 
autism [118] .It has 
been suggested that 
exposure to antibiotics 
may be related to 
deleterious effects on 
the microbiome [119]   
None found 
Selective serotonin re uptake 
inhibitors (Percentage use in the test 
group comprised 44% fluoxetine, 
21% sertraline, 19% paroxetine, 8% 
citalopram, and 8% escitalopram) 
Prenatal use in the first 
trimester associated 
with autism 
development in boys 
[120].  
Fluoxetine has also 
been shown to alleviate  
serious and pervasive 
repetitive behaviours in 
the clinic in later life 
[121] 
Psychoactive compounds 
are also environmental 
pollutants and mixtures can 
be found, at low 
concentrations, in drinking 
water. At such 
concentrations, a mixture of   
fluoxetine, carbamazepine 
and venlafaxine, or 
valproate produce 
expression changes in genes 
related to neuronal growth, 
development and 
regulation, and to autism in 
SK-N-SH neuroblastoma 
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cells  [122]. Neonatal 
fluoxetine administration in 
rats impairs motor 
coordination in neonates 
and decreased social 
behaviour in both juvenile 
and adult offspring [123] 
Terbutaline β2-adrenergic receptor 
agonist, used as a tocolytic (anti-
contraction medication) to delay 
preterm labour for up to 48 hours 
Terbutaline exposure 
for >2 days during the 
third trimester 
associated with a  
fourfold increased risk 
for autism spectrum 
disorders (not observed 
with albuterol) [124] 
In rats, maternal stress 
during pregnancy, or 
terbutaline administration to 
the neonates, on postnatal 
days 2-5  resulted in 
autistic-like behaviour in 
the offspring 
(stereotyped/repetitive 
behaviour and deficits in 
social interaction or 
communication[125]. 
Newborn rats treated with 
terbutaline (10 mg/kg) daily 
on postnatal days 2 to 5 or 
PN 11 to 14 showed a 
robust increase in 
microglial activation on 
postnatal day 30 in the 
cerebral cortex, as well and 
in cerebellar and 
cerebrocortical white 
matter. hyper-reactivity to 
novelty and aversive stimuli 
was also observed [126].  
Oxytocin Labour induction or 
augmented labour 
associated with an 
increased risk of 
subsequent autism 
(exogenous oxytocin 
and prostaglandins) 
[127]. Oxytocin also 
has reported benefits in 
the treatment of autism 
later in life, although 
meta-analysis of 12 
randomized controlled 
trials suggested little 
consistent effect [128].  
Oxytocin plays a generally 
beneficial role in sociability 
in animal models [129,130]. 
Autism related behaviour is 
observed in oxytocin or 
oxytocin receptor knockout 
mice [131]. 
Prostaglandins: Pharmacological 
methods  for labour induction  
mainly include dinoprostone 
(prostaglandin E2: PGE2 ) or 
Labour induction or 
augmented labour 
associated with an 
increased risk of 
PGE2 modulates cerebellar 
development in the early 
postnatal period in rats and 
alters sensory threshold and 
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misoprostol (a prostaglandin E1 
analogue) 
subsequent autism 
(exogenous oxytocin 
and prostaglandins) 
[127]. PGE2 plasma 
levels increased in 
autistic patients [132] 
social behaviour in juvenile 
males but not females 
[133]. 
Thalidomide  Prenatal use also 
associated with autistic 
features [134-136] 
The prenatal administration 
of thalidomide in rats 
produces   abnormal 
serotonergic neuronal 
differentiation and 
migration and behavioural 
effects partly consistent 
with autism [137,138]  
Valproate Maternal exposure 
during pregnancy 
associated with autism 
(reviewed in [139-141] 
Valproate exposure in both 
rats and mice leads to 
autistic-like behaviour in 
the offspring, including 
social behaviour deficits, 
increased repetitive 
behaviour, and deficits in 
communication [141]. 
Other drugs 
Cannabis ADHD symptoms and 
autistic traits scores 
have been associated 
with elevated levels of 
regular smoking; 
cannabis use; and 
nicotine, alcohol, and 
cannabis use disorders 
[71] 
None found 
Cocaine Maternal use in the 
perinatal period 
associated with autism 
[142] 
None found 
dexamethasone Reduced 
dexamethasone 
suppression in autistic 
patients [143] 
Dexamethasone treatment  
during pregnancy in mice ( 
gestational days 16-19 ) 
increases  astrocyte density 
in the adult offspring 
Substantia nigra and ventral 
tegmental area  in both 
males and females and 
increases  tyrosine 
hydroxylase 
immunoreactivity in these 
areas in both sexes, but with 
a more pronounced effect 
on Tyrosine hydroxylase 
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positive cell density in 
females [144]. 
Ethanol  Prenatal use associated 
with autism [135,145] 
In utero exposure of mouse 
progeny to alcohol or 
methamphetamine causes 
postnatal 
neurodevelopmental deficits 
. mediated partly  by 
oxidative stress [146]. 
Methamphetamine Case report of autism 
related to prenatal 
exposure [147] 
In utero exposure of mouse 
progeny to alcohol or 
methamphetamine causes 
postnatal 
neurodevelopmental deficits 
. mediated partly  by 
oxidative stress [146]. 
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Methods 
206 Autworks autism susceptibility genes (ASG’s) 
http://tools.autworks.hms.harvard.edu/gene_sets/580/genes  [9] were analysed. Gene 
definitions are provided in supplementary File 1. Members of this gene set are highlighted in 
bold when they appear in the text. The gene symbols (applicable to human genes and mouse 
or rat homologues) were uploaded to the Comparative Toxicogenomics Database (CTD) [20] 
http://ctdbase.org/ . All interactions are referenced at CTD and can be accessed by uploading 
the gene symbols from the Autworks dataset.  The results were downloaded and the number 
of ASG’s and the total number of genes (autism and others) affected by each chemical or the 
number of chemicals affecting each autism gene were curated manually. Chemicals were 
broadly classified into groups (e.g. pesticides, metals, endocrine disruptors). Singletons 
(chemicals affecting only one gene) were ignored.  Many clinical and research drugs were 
returned, but are not treated in this paper.  
All chemicals possess a unique CAS registry number, from the American Chemical society 
Chemical Abstracts Service  http://www.cas.org/content/chemical-substances  allowing 
cross-referencing between CTD data and compounds in other databases. Overlaps were 
identified using the Venny tool http://bioinfogp.cnb.csic.es/tools/venny/  [148] . 
The databases used for such classification, based largely on overlapping CAS numbers, 
included The TEDX List of Potential Endocrine Disruptors http://endocrinedisruption.org/  ; 
The EU list of endocrine disruptors http://eng.mst.dk/topics/chemicals/endocrine-
disruptors/the-eu-list-of-potential-endocrine-disruptors/ ,the  NIST Polycyclic Aromatic 
Hydrocarbon  (PAH) Structure Index http://pah.nist.gov/ ,the  national toxicity program from 
the US department of health http://ntp.niehs.nih.gov/index.cfm  and the United States 
Environmental protection agency databases http://www.epa.gov/ .Persistent organic 
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pollutants (POPs) are as defined by the Stockholm convention 
http://chm.pops.int/Home/tabid/2121/mctl/ViewDetails/EventModID/871/EventID/514/xmid/
6921/Default.aspx . 
Compounds in cigarettes are defined by the Federal drug administration 
http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm2977
86.htm and the Tobacco Products Scientific Advisory Committee list of harmful or 
potentially harmful components in tobacco and/or tobacco smoke  [149]. 
Compounds found in diesel exhaust are listed at Wikipedia 
http://en.wikipedia.org/wiki/Diesel_exhaust and at the United States department of labor 
Partial List of Chemicals Associated with Diesel Exhaust 
https://www.osha.gov/SLTC/dieselexhaust/chemical.html  
Lists of chemicals in cosmetics, foods and pharmaceutical preparations were obtained from 
the National Research Council (US) Steering Committee on Identification of Toxic and 
Potentially Toxic Chemicals for Consideration by the National Toxicology Program [150], 
the UK Food standards agency listing EU approved food additives http://www.food.gov.uk/ 
and from the International fragrance association 
http://www.ifraorg.org/en/ingredients#.U_w5JWNWpZx . Food ingredients were also 
interrogated at FooDB http://foodb.ca/compounds a project from the Canadian Metabolomics 
Innovation Centre.  Food additives are also listed at GSFA online 
http://www.codexalimentarius.net/gsfaonline/additives/index.html from the Joint FAO/WHO 
Expert Committee on Food Additives (JECFA) and from the List of Indirect Additives Used 
in Food Contact Substances from the US Food and drug administration 
http://www.accessdata.fda.gov/scripts/fcn/fcnNavigation.cfm?rpt=iaListing and the EAFUS 
list (Everything Added to Food in the United States) 
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http://www.accessdata.fda.gov/scripts/fcn/fcnNavigation.cfm?rpt=eafusListing&displayAll=t
rue  . 
The Consumer Product Information Database (CPID 
http://whatsinproducts.com/contents/about_cpid/1  was use for ingredients found in 
household products. Chemicals in household products were identified using the National 
Institute of health Household Products database http://householdproducts.nlm.nih.gov/cgi-
bin/household/search . 
It is important to appreciate that the only selection criteria were the 206 autism genes which 
were sent to forage chemical interactions in an extensive toxicogenomics database, and that 
the compounds returned are essentially unbiased by any other factor. However, certain 
compounds, such as dioxins, pesticides or heavy metals have been more intensively studied 
than others, due to their known toxic effects, while other relatively new chemical additions to 
the environment have been subject to less scrutiny. The total number of genes affected by 
each compound is therefore shown on each figure to allow appreciation of such effects. 
Gene enrichment analysis. 
The ASG’s, selected by Autworks by confidence score based on Genotator, number 206 
(0.77% from a human genome of 26,846 protein-coding genes). There were 10,766 unique 
chemicals in CTD, with 1,002,333 curated interactions (2015 data). If a chemical affects N 
genes, one would expect an equal proportion of ASG’s (0.77%) to be contained within this 
gene set (Expected = N*(206/26846)). Chemical bias towards the ASG’s is reflected by 
observed/expected ratios >1 and the corresponding p value derived from the hypergeometric 
probability test, which was corrected for false discovery [151], with a final cut-off at P<0.05.  
Most results are illustrated graphically. For individual compounds the data are illustrated by 
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N autism genes affected/total number of genes affected by the compound, followed by the 
fold enrichment and p values (e.g. Methionine (69/3724: 2.41 fold: P= 2.E-12). 
Results 
67861 chemical/gene interactions affected the ASG’s. 4428 compounds affected 1 or more 
ASG’s. 6338 chemicals did not interact with any autism gene.  The number of ASG’s 
targeted by each chemical varied from 1 to 141 (Tetrachlorodibenzodioxin). The number of 
chemicals affecting each autism gene ranged from 0 to 1669. 760 compounds with significant 
enrichment values affected ≥5 ASG’s; 372 ≥10; 109 ≥25; 29 ≥50 ; 6 ≥100 . Enrichment 
values (observed/expected ASG’s per total number of genes affected by each compound) for 
these significant chemicals, where the number of ASG’s targeted > 5 ranged from 1.4 to 97.7.  
No chemical interactions had been curated for HTR3C, KLF14, RP1L1 or ZNF778  
Genes affected by compounds implicated in autism (Fig 1) 
Of the named pollutants implicated in autism (see Table 1) 45 showed enrichment values at P 
< 0.05 (all except Nickel, diethyl phthalate, Nitrogen Dioxide and Vinyl Chloride) 
Compounds with the most significant enrichment scores were pesticides (diazinon, 
chlorpyrifos, Dichlorodiphenyldichloroethylene (DDE: a DDT metabolite) and 
cypermethrin), and metals (arsenic, zinc, mercury and cadmium) Other highly significant 
pollutants included the flame retardant PCB-153, nitric oxide, Bisphenol A, benzo(a)pyrene, 
particulate matter and ozone (Fig 1).   
Figure 1.  The number of ASG’s (where N>=5) affected by pesticides, herbicides, heavy 
metals and other named pollutants implicated in autism (left axis). The enrichment ratio and 
the total number of genes affected by each compound are shown after each compound name. 
For example Diazinon affects 274 genes in total, 30 of which are ASG’s, yielding an 
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enrichment value (observed/expected) of 14.26. (Diazinon (14.26|274). FDR corrected p 
values are shown on the right hand Y axis, which is set at a maximum of p=0.05. TCDD= 
Tetrachlorodibenzodioxin. DDT = dichlorodiphenyltrichloroethane: DDE= Dichlorodiphenyl 
Dichloroethylene (DDT metabolite). DIEH Phthalate = Diethylhexyl Phthalate , PCB-153 
=2,4,5,2',4',5'-hexachlorobiphenyl; PCB-138  =2,2',3',4,4',5-hexachlorobiphenyl (Both PCB’s 
are flame retardants). 
3-phenoxy benzoic acid (pyrethroid metabolite), Dicofol , Sulphur Dioxide, Chlordan , 
acephate ,cyhalothrin, quinoline, 3-xylene  and 1,3-butadiene overlaps were also significant 
but affected less than 5 ASG’s (not shown) . 
 
Drugs with the most significant enrichment scores included SSRI antidepressants (fluoxetine, 
sertraline, paroxetine, citalopram); thalidomide, drugs of abuse (cocaine, methamphetamine, 
30 
 
and ethanol); nicotine, steroid drugs (dexamethasone and hydrocortisone) and drugs used to 
induce (Dinoprost, misoprost, oxytocin) or prevent (terbutaline) labour in pregnancy, as well 
as thalidomide, acetaminophen, thimerosal and valproate (Fig 2). There have been multiple 
conflicting studies relating to the risks and benefits of Thimerosal containing vaccines, which 
have resulted in its withdrawal in many countries [152]. Thimerosal was removed from 
childhood vaccines in the USA in 2001. 
http://www.cdc.gov/vaccinesafety/Concerns/thimerosal/index.html . 
Thimerosal affects 8 autism genes (GSTM1, IL6, MAPK1, MAPK3, PTK2, RFC1, SLC1A1 
and TNF) and its relatively minor enrichment effects (compared to many industrial and other 
pollutants) may well be limited to those with particular polymorphisms in this set. It should 
be noted that recent meta-analyses do not support a significant effect of thimerosal in relation 
to autism [153,154] and that the rise in the incidence of autism has continued since its 
withdrawal[155].  79 other compounds significantly oriented their effects towards > 10 
ASG’s, 39 >20 ASG’s and 16 > 30 ASG’s and these are likely of greater concern. 
Together, these results show that many industrial, agrochemical and household pollutants or 
drugs implicated in autism target multiple ASG’s. One evident interpretation is that 
polymorphisms therein may modify sensitivity to autism-related chemicals. This is discussed 
in a later section. Using a similar experimental approach Kauchik et al constructed a 
protein/protein interaction (PPI) network of autism related genes and found that the effects of 
drug mixtures (environmental contaminant concentrations of carbamazepine, venflaxine and 
fluoxetine) or clinical concentrations of valproate on gene expression in fish brains or in 
human neuronal cell cultures tended to target the same networks as those identified in the 
autism PPI interactome [156]. 
Figure 2. 
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The number of ASG’s affected by drugs implicated in autism (left axis), and p values (right 
axis). The enrichment ratio and the total number of genes affected by each compound are 
shown after each compound name. First batch = SSRI antidepressants, second = drugs of 
abuse, third = drugs used during labour, fourth =others. 
 
 
 
 
 
Other pesticides, fungicides and herbicides 
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Many pesticides, other than those reportedly related to autism (see Fig 1), are used 
agriculturally or in the home, often together or at different seasons. 41 of these targeted 
multiple autism genes (P< 0.05) (Fig 3). In the various classes, Cycloheximide, Maneb, 
Vinclozolin and mancozeb were the most significant fungicides; Paraquat, Cyanazine, 
Atrazine and herbimycin the most significant herbicides and Methoxychlor, Dieldrin, 
Endosulfan and chlorpyrifos oxon the highest scoring insecticides.  
Figure 3.  
The number of ASG’s affected by diverse pesticides (left axis), and p values (right axis). The 
enrichment ratio and the total number of genes affected by each compound are shown after 
each compound name. The compounds are divided by class: “Others” includes diverse broad-
spectrum pesticides and Cyanimide, which is widely used in agriculture to promote uniform 
opening of buds, early foliation and bloom in fruits. Metdithocarb= methyldithiocarbamate. 
33 
 
.
 
 
Other metals  
For the most part, other metals significantly orienting their effects towards the ASG’s were 
salts of those already shown in Fig 1 (arsenic, zinc, cadmium, mercury, lead, copper, 
aluminium) (not shown) ). Asbestos, Crocidolite (28/682: 5.4 fold: p= 2.1E-12) is blue 
asbestos, a product linked to many cancers but not studied in relation to autism. The metals 
also included the highly toxic tributyltin (10/228: 5.7 fold: p=2.45E-05), a suspected 
carcinogen, cobaltous chloride (49/3281: 1.95 fold: p= 4.92E-06. Titanium dioxide (50/3449: 
1.8 fold: p=8.3E-06) and silicon dioxide (37/2789: 1.7 fold: p=0.0006) are included in the 
EAFUS and cosmetics lists and treated in these sections.  
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Poly-halogenated biphenyls, flame retardants, bisphenols and phthalates . 
4 known flame retardants (all polybrominated biphenyls) and 12 polychlorinated biphenyls 
showed significant enrichment values in relation to the ASG’s as did several bisphenols and 
phthalates (Fig 4). During the revision of this paper, high serum levels of PCB-153 and PCB-
138 in banked maternal second trimester serum samples were shown to be related to 
increased autism risk [107]. Both are enriched in ASG’s (Fig 4). 
Figure 4.  
The number of ASG’s affected by diverse polyhalogenated biphenyls, bisphenols and 
phthalates (left axis) and p values (right axis). The enrichment ratio and the total number of 
genes affected by each compound are shown after each compound name. Flame= Flame 
retardants. Methoxyacetic acid is a di(2-methoxyethyl) phthalate metabolite. PBDE-47 
=2,2',4,4'-tetrabromodiphenyl ether; PDBE =pentabromodiphenyl ether; PBDE 209 
=decabromobiphenyl ether; HBCD hexabromocyclododecane; PCB-153 =2,4,5,2',4',5'-
hexachlorobiphenyl; 24-TCB =2,4,2',4'-tetrachlorobiphenyl; PCB 138  =2,2',3',4,4',5-
hexachlorobiphenyl; PCB-28  =2,4,4'-trichlorobiphenyl; PCB-95  =2,2',3,5',6-
pentachlorobiphenyl; PCB 104  =2,2',4,6,6'-pentachlorobiphenyl; 4-OH-PeCB1  =2',3,3',4',5-
pentachloro-4-hydroxybiphenyl; PCB 101 =2,4,5,2',5'-pentachlorobiphenyl; PCB-126  
=3,4,5,3',4'-pentachlorobiphenyl; PCB 180 =2,2',3,4,4',5,5'-heptachlorobiphenyl; PCB 52 
=2,5,2',5'-tetrachlorobiphenyl; PCB-77  =3,4,3',4'-tetrachlorobiphenyl; DGEBA   =bisphenol 
A diglycidyl ether ; TBBPA =tetrabromobisphenol A; DEHP =Diethylhexyl Phthalate; 
MEHP =mono-(2-ethylhexyl|phthalate; DBP =Dibutyl Phthalate 
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Persistent organic pollutants (POP) and Polycyclic aromatic hydrocarbons (PAH). 
Several of these compounds, already recognised for their toxicity in many domains 
significantly targeted the ASG’s (Fig 5). A large number of genes were targeted by 2,3,7,8-
Tetrachlorodibenzodioxin and Benzo(a)pyrene.  
Figure 5. The number of ASG’s affected by diverse Persistent organic pollutants (POP) and 
Polycyclic aromatic hydrocarbons (PAH). (left axis), and p values (right axis). The 
enrichment ratio and the total number of genes affected by each compound are shown after 
each compound name. DDT =dichlorodiphenyltrichloroethane;  TCDD = 2,3,7,8-
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Tetrachlorodibenzodioxin; 9,10-DM-benzan = 9,10-Dimethyl-1,2-benzanthracene; 7,8-
DHBPO = 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide. 
 
 
 
 
 
 
Endocrine disruptors 
138 compounds within this class significantly oriented their effects towards 5 or more autism 
genes, 79 > 10 genes, 39 >20 genes, 16 > 30 genes (P<0.05). Many of these compounds are 
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in the EAFUS list or in food, as plant constituents (e.g. phytoestrogens) or contaminants (e.g. 
alkylphenols). Many are also found in cosmetics or household products and these classes are 
coded for in Fig 6. Several of these compounds, for example pesticides, heavy metals, 
bisphenols and phthalates, have already been treated above and are not included in Fig 6.  
The highly significant endocrine disruptors also include several used in cosmetics including 
bisphenol A, nonylphenol, Butylated Hydroxytoluene, Butylated Hydroxyanisole, beta 
Carotene, 4-propylphenol, Styrene, acetyl methyl tetramethyl tetralin, 4-cresol, 4-
ethylphenol, Resorcinol, Phenol, Ethylene Glycol, Propylparaben and n-hexane. Several 
plant-derived phytoestrogens, flavones/flavonoids, selectively target these genes (Apigenin, 
daidzein, Genistein, kaempferol, Luteolin, naringenin, resveratrol and quercetin). They are 
common components of food supplements, including baby milk, follow-ons, and soy formula 
[157-159].    They are generally regarded as potentially beneficial in a number of conditions 
including cancer, type 2 diabetes, obesity, coronary heart disease, metabolic syndrome, and 
neurodegenerative diseases. (e.g. resveratrol [160]). Phytoestrogens stimulate estrogen 
receptors, alpha and beta  and many are endowed with antioxidant, and pro-apoptotic effects 
[161], while some may also have pro- or anti-angiogenic effects [162]. Certain isoflavones 
inhibit thyroperoxidase activity and may thus influence the thyroid receptor. These processes 
are important in relation to placental physiology and/or to neurodevelopment  [163,164,164] . 
Endocrine disruptors, including Bisphenol A and polychlorinated biphenyls , but also  dietary 
phytoestrogens are known to affect neurodevelopment in rodents [163,165] Luteolin and 
quercetin have been reported to reduce autism symptoms in a small clinical trial [166].  
However, such compounds are not bereft of toxicological effects. For example neonatally 
administered genistein in mice later reduces female fertility and embryo implantation [167]. 
It is also embryotoxic in rats and synergises with Bisphenol A in this respect [168,169]. Pre- 
or perinatally administered phytoestrogens can also have deleterious effects on animal 
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behaviour. For example adult male mice perinatally exposed to daidzein show significantly 
less exploration and higher levels of anxiety and aggression [170]. Genestein given to rat 
dams during late pregnancy and early lactation  affects  the differentiation of brain structures 
as well as changes in anxiety and aggressive behaviour in the male offspring 
[171].Phytoestrogens can be found in pregnant women's serum and amniotic fluid during 
pregnancy and soy  ingestion increases amniotic fluid phytoestrogen concentrations in female 
and male foetuses [172] . The use of Soy infant formula has indeed been linked to Autistic 
behaviour in one study [113].  
These endocrine disruptors also include Sodium Fluoride, which is added to domestic water 
supplies for dental health in many countries. NaF decreases fertility in female rats, via 
decreases in serum estradiol and progesterone levels and the uterine expression of the follicle 
stimulating hormone receptor. It also increases uterine estrogen receptor alpha (ESR1) and 
progesterone receptor and luteinising hormone receptor protein expression levels (400;401). 
In mouse Leydig tumor cells NaF decrease the mRNA expression of steroidogenic acute 
regulatory protein (STAR) and a cytochrome P450 (CYP11A1) which catalyses the conversion 
of cholesterol to pregnenolone, the first rate-limiting step in the synthesis of steroid hormones 
(402). When given to pregnant rats, NaF decreases the activity levels of testicular 
steroidogenic marker enzymes (3beta hydroxysteroid dehydrogenase and 17beta 
hydroxysteroid dehydrogenase) in the 90 day old male offspring (403). Dietary NaF also 
decreases the serum levels of free and bound triodothronine and thyroxine in rats (404) 
NaF also decreases the expression of CYP1A2 in mouse spermatozoa (405). CYP1A2 
metabolises polycyclic aromatic hydrocarbons, dioxins, polychlorinated dibenzofurans, 
polychlorinated biphenyls, and acetaminophen (406).  NaF thus possesses endocrine 
disrupting properties and an ability to affect the metabolism of a number of environmental 
agents implicated in autism.  
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Figure 6. The number of ASG’s affected by diverse known (first batch) and potential (second 
batch) endocrine disruptors. N ASG’s =left axis, p values =right axis). The enrichment ratio 
and the total number of genes affected by each compound are shown after each compound 
name. Also appended are compounds found in Food (plant constituents or contaminants (F), 
the EAFUS list of food additive (E), Cosmetics (C) and household objects (H). Myco = 
mycotoxin; BDPB = 1,4-bis(2-(3,5-dichloropyridyloxy))benzene; BHA = Butylated 
Hydroxyanisole; BHT= Butylated Hydroxytoluene;  
 
Components of cigarette smoke or diesel exhaust. 
Many chemicals found in diesel and/or cigarette smoke significantly targeted a number of 
ASG’s (Fig 7). Their effects must be considered as cumulative. 
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These data suggest a relationship between the cumulative effects of smoking or diesel 
toxicants and ASG’s. In relation to diesel and traffic pollution, a recent review has 
highlighted air pollution as a contributory factor to both neurodevelopmental and adult 
neurodegenerative disorders [69]. 
 
Figure 7: The number of ASG’s affected by compounds found in cigarette smoke or diesel 
exhaust or in both. N ASG’s =left axis, p values =right axis). The enrichment ratio and the 
total number of genes affected by each compound are shown after each compound name. 
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Endogenous compounds targeting the autism genes.  
Neurotransmitters, hormones and key endogenous signalling and other metabolites are the 
agents through which genes and environmental factors act to influence pathology and 
behaviour. By inference, pollutants that target the same genes/proteins as those related to 
endogenous messengers must interfere with their function. As shown below, many of the 
endogenous agents that target autism genes clearly relate to autism pathology and behaviour.  
Autism genes are targeted by relevant hormones and transmitters (Fig 8). 
Compounds with the most significant enrichment scores (tretinoin (=all-trans retinoic acid), 
melatonin, progesterone and estradiol) demonstrate a key influence of retinoids and sex 
hormones that is relevant to the suspected role of environmental endocrine disruptors in 
autism [173] and to the important role of melatonin in autism [174,175]  Many other 
hormones (thyroxine, triiodothyronine, corticosteroids, calcitriol (1,25-dihydroxyvitamin D3, 
the hormonally active metabolite of vitamin D, and testosterone )) also showed significant 
enrichment scores. Low vitamin D status during pregnancy or childhood has also been 
associated with autism [176]. Severe maternal hypothyroxinaemia during early pregnancy has 
also been linked to an increased incidence of autism in the offspring [177]. 
The highest scoring neurotransmitters were serotonin , dopamine and noradrenaline, which is 
generally consistent with current views on the import of these agents in autism pathology and 
symptomatology [174,178,179]. Sphingosine-1-phosphate (S1P) plays an important role in 
oligodendrocytes and in myelination [180]. Aberrant myelination, greater than expected for 
their age in left and right medial frontal cortex and less than expected in the left temporo-
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parietal junction has been noted in autistic children and  high serum levels of S1P have been 
reported in a metabolomics study of autistic subjects [181].As recently reviewed, oxytocin 
has both beneficial and deleterious effects in autism. While its use to induce labour has been 
linked to the subsequent development of autism in the children, it can also help in relation to 
the social skills in autistic patients [182] .   
Also of interest is an endogenous aryl hydrocarbon receptor (AHR) ligand ( 2-(1'H-indole-3'-
carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE). [183] .  AHR is a xenobiotic sensor 
and the target of dioxins, persistent organic pollutants, polycyclic aromatic hydrocarbons, 
polychlorinated biphenyls, organochlorine pesticides and endocrine disruptors  [184,185], 
many of which are the top chemicals targeting the autism genes [186-188]. There appear to 
have been no studies relating AHR to autism.  
Calcium is directly relevant to 3 calcium channels CACNA1C, CACNA1G, CACNA1H in the 
autism gene set. Voltage sensitive calcium channels play an important role in neural function. 
They are also expressed in the placenta and trophoblast and play an important role in the 
delivery of calcium to the foetus [189,190].Heavy metal cations, particularly lead and 
mercury, are potent calcium channel blockers but can also permeate these channels, gaining 
access to the cell [191]. 
Figure 8: The number of ASG’s affected by Hormones (first batch) and transmitters (second 
batch: including cations and second messengers). (N ASG’s =left axis, p values =right axis). 
The enrichment ratio and the total number of genes affected by each compound are shown 
after each compound name. 
 (ITE = 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester. Galactosamine is 
included as it is a constituent of some glycoprotein hormones (follicle-stimulating hormone 
and luteinizing hormone). 
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Other endogenous compounds targeting autism genes 
These are grouped by general function in Fig 9. They include compounds related to oxidative 
stress and folate/methionine/homocysteine metabolism which play key roles in autism [192-
195]  as do cholesterol and fatty acid metabolism [196-199] or inflammation [200-203].. 
Several bile related compounds appear in this figure. Bile acids act as nutrient signalling 
hormones and activate a number of nuclear receptors and G-protein coupled receptors 
including a specific bile acid receptor GPBAR1 which regulates intestinal barrier structure via 
modification of epithelial tight junctions [204]. Many of the ASG’s are implicated in barrier 
function and intestinal permeability increases (leaky gut) have been reported in autism 
[11,205]. No studies relating bile acids to autism were found in Pubmed, but this area appears 
to be of interest. 
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It is important to note that compounds generally considered as beneficial in relation to autism 
also target autism genes (see discussion caveats). These include folic acid (see above) , 
glutathione and its precursor acetylcysteine which has reported benefits in the treatment of 
autism and related psychiatric disorders [206] as might vitamins [207,208] . 
Thioctic acid or alpha-lipoic acid is an essential coenzyme for α-ketoglutarate and pyruvate 
dehydrogenase and thus an obligate requirement for energy production[209].  Lipoic acid 
protects against the effects of Bisphenol A or Bi-n-butyl phthalate on testicular mitochondrial 
toxicity [210,211]. In various other models it also protects against the toxic effects of 
acetaminophen [212], acrolein [213], cyclosporine [214], indomethacin [215], paraquat [216] 
and rotenone [217] as well as cypermethrin [218], dimethoate, glyphosate and zineb 
[219],chrysene [220] lindane [221] and Tetrachlorodibenzodioxin [222]. Lipoic acid and 
other antioxidants have also been used in the clinical management and prevention of heavy 
metal intoxication [223]. The targeting of autism genes by this product may  thus reflect 
beneficial rather than deleterious effects and, in particular, lipoic acid protects against a large 
number of toxicants that target autism genes and which have been implicated in the disorder.  
It has not been analysed in epidemiological studies or tested in the clinic, and blood or tissue 
levels do not appear to have been measured in pregnancy, neonates or autistic children.  
The effects of some fatty acids and carnitine are also oriented towards the ASG’s.  Faecal 
levels of acetic, butyric, other short chain fatty acids and ammonia are increased in autistic 
children, related to microbiome alterations  [224,225]. Reduced serum carnitine and linoleic 
acid levels and modified  omega3/omega6 fatty acid ratios have also been noted in autism 
[226]. 
Figure 9: The number of ASG’s affected by diverse endogenous compounds (N ASG’s =left 
axis, p values =right axis). The enrichment ratio and the total number of genes affected by 
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each compound are shown after each compound name. The compounds are organised in 
relation to their general function. 
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Food additives and compounds in cosmetics targeting the autism genes (Fig 10) 
70 compounds in the EAFUS list targeted >5 autism genes (P<0.05) .The interactomes of 
several compounds which might be considered beneficial (folic acid, methionine, ascorbic 
acid, niacin and oleic acid) were significantly enriched in autism genes. (Methionine 
(69/3724: 2.41 fold: P= 2.E-12); Folic Acid (68/3635: 2.44 fold: P=2.03E-12); Ascorbic Acid 
(24/561: 5.6 fold: p=4.52E-11); Niacin (12/136: 11.5 fold: P=2.58E-09); Oleic Acid (6/85: 
9.2 fold: p=0.0001). 
 Ammonium chloride, the highest scoring compound, derived from burning coal is also used 
as a flavour enhancer. Ammonium hydroxide in brine solutions is used as a meat tenderiser 
(363) and is also widely used in food processing to increase pH, while ammonia gas is used 
to kill bacteria in ground beef (364).  NH4Cl might be considered as a potential by-product of 
such procedures due to reaction with salt or gastric hydrochloric acid.  No reports in relation 
to autism could be found. However NH4Cl (Fig 11) increases the permeability of 
cerebrovascular pial venular capillaries [227] and that of the blood brain barrier to creatine 
[228] and increases gastric permeability to hydrogen ions [229]. It is also an expectorant used 
in cough medicines and is able to increase the beat frequency of respiratory cilia [230].   No 
relationships with autism or neurodevelopment have been reported. Given the barrier and 
ciliary  function of many autism genes [11], it is perhaps this aspect rather than 
neurodevelopmental criteria that provides such a high score.   
It is not practical, given space limitations, to discuss all of these compounds whose 
relationships with autism or to barrier function remain to be analysed. There are several 
however that are perhaps of more interest than others due to their extensive use (aspartame, a 
49 
 
constituent of over 6000 food products) or as anticaking agents that are also constituents of 
widely used sunscreens (Titanium dioxide , silicon dioxide, and zinc oxide).  
Aspartame acts via sweet taste receptors TAS1R2 /TAS1R3 [231] and also activates transient 
receptor potential heat and inflammation sensitive channels (TRPV1). These are involved in 
metallic taste perception as they are also activated by copper, zinc and iron sulphates [232]. 
TAS2R1, within the autism gene set, is a bitter taste receptor. Recent evidence suggests that 
such receptors, also found in areas outside the mouth, may activate defensive mechanisms 
against noxious chemicals including cytokine and immune systems.  In the human lung, 
TAS2 receptors are expressed in the cilia that sweep harmful chemicals, particles, and 
microbes from the airways [233]. TAS2 receptor activation in nasal cells results in the 
secretion of antimicrobial peptides, an effect inhibited by TAS1R2 /TAS1R3 sweet activation 
[234]. Thus, aspartame, excessive glucose and other sweet substances activating TAS1 
receptors would be expected to inhibit the clearing of pathogens and noxious chemicals 
stimulated by TAS2 receptor activation.  
Microbiome profiling has shown that low-dose aspartame, which has also been implicated in 
the development of obesity and metabolic disease, increases total bacteria, the abundance of 
Enterobacteriaceae and Clostridium leptum in diet-induced obese rats. It also increases the 
serum levels of the short chain fatty acid propionate [235].High levels of faecal 
enterobacteria and Clostridial families have also been reported in autism [236]. The 
intracerebroventricular administration of propionate in rats induces behavioural and 
pathological signs that are relevant to autism [237-240]  . 
Titanium and silicon dioxide (silicon dioxide (37/2789 : 1.7 fold p=0.0006: not on figure) are 
used, often in nanoparticle form, in a large number and variety of commercial products 
including pigment colours, anti-bacterial and other pharmaceutical components, ultraviolet 
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radiation scavengers (sunscreens), as well as in cosmetics. Both are also food additives used 
as anticaking agents or colorants [241,242]. Their risks are generally uncharacterised in 
epidemiological studies although they are manufactured and used worldwide in large 
quantities [243]. Zinc oxide is also used as a sunscreen. 
Titanium dioxide nanoparticles are internalised by human neuronal SHSY5Y cells and induce 
dose-dependent cell cycle alterations, apoptosis, and genotoxic effects that appear to be 
unrelated to oxidative damage [244].  In contrast, in human epidermal cells, they reduce 
glutathione and increase lipid hydroperoxide and reactive oxygen species levels, leading to 
genotoxicity via oxidative DNA damage [245]. Titanium nanoparticles also suppress 
angiogenesis [246,247]. 
Both titanium and silicon dioxide nanoparticles cross the placental barrier in mice and can be 
found in foetal liver and brain following maternal administration. Such treatment results in 
smaller uteri and foetuses [248]. Titanium dioxide nanoparticles accessing the nasal or 
pulmonary route are also translocated to the brain or the systemic circulation and thence to 
other organs [249]. The prenatal administration of titanium dioxide nanoparticles in rats 
increases frontal cortical and neostriatal dopamine levels in the offspring [250] and modifies 
the expression of neurodevelopmental genes in the brains of the young offspring in mice 
[251] .  Both silicon and titanium dioxide nanoparticles activate inflammatory cascades in 
microglia and the supernatants collected from the treated microglia are cytotoxic to PC12 
neuronal cells [252]. Titanium dioxide nanoparticles are also internalised by microglial cells 
resulting in an inhibition of cell adhesion and an overproduction of superoxide [253].  
Beta-ionone (EAFUS/cosmetics) is also formed in animals by beta-carotene oxygenase 2 
(BCO2) which converts  betacarotene  to β-10'-apocarotenal and β-ionone, en route to the 
synthesis of Vitamin A [254]. It does not activate retinoid receptors RARA or RARB [255] but  
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binds to a retinol binding protein, beta-lactoglobulin B,  involved in the oral delivery of 
retinol to neonates [256]. It is a potent inhibitor of a mouse retinal dehydrogenase (raldh4: 
human homologene = ALDH8A1). These enzymes catalyze the dehydrogenation of retinal 
into retinoic acids,  which are required for embryogenesis and tissue differentiation [257].  
Fig 10. Compound on the EAFUS list that target the ASG’s The maximum left and minimum 
Y axes are truncated for clarity (NH4Cl affected 119 autism genes : p= 7.78E-44). BHT = 
butylated hydroxytoluene; PTCH = protocatechuic acid (a major metabolite of antioxidant 
polyphenols found in green tea.) TMP= tetramethylpyrazine. Compounds also found in 
cosmetics are appended with C and those in household products with H. 
 
Cosmetic ingredients targeting autism genes. 
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Several of these are also in the EAFUS list (see above) and may be used in both as solvents 
or fragrances and only those specific to cosmetics or not dealt with above are shown in Fig 
11. In relation to cosmetics it has recently been reported that many perfumes are mutagenic at 
femtomolar concentrations [258]. They also reduce arginine vasopressin receptor and 
oxytocin receptor positive   neurons in male neuroblastoma cells, but not in female cell lines. 
In both male and female neuroblastoma cells fragrances (1 in 1 million dilutions of the shelf-
marketed product, all ingredients included) also induced neuronal proliferation, central 
chromatolysis, enlargement of the neuronal cell body, shortening or abnormal increase and 
thinning of axonal length, syncytia formation, or selective neurotoxicity [259]. 
Tretinoin, (all-trans retinoic acid) is the highest scoring compound. It is used for acne and as 
an anti-ageing component in face creams [260] and is available, without prescription, on 
many websites. Tretinoin treatment in pregnant rats results in postnatal mitochondrial 
complex 1 dysfunction in the cerebellum of the offspring [261] and has also been shown to 
increase levels of fear and anxiety in offspring [262]. Gestational treatment also results in a 
delayed appearance of the cerebellar righting reflex and reduces open-field activity in the 
offspring. In addition the offspring  show impaired motor coordination and motor learning 
ability coupled with a reduction in the cerebellar size and impairment in the cerebellar 
foliation profile [263,264]. A 3 day exposure to 2.5 mg/kg tretinoin (gestational days 11-13) 
produces a 10% reduction in weight of cerebellum at 4 weeks of age, not accompanied by 
other malformations [265]. In rats treated with retinoic acid at gestational day E10, the 
foetuses show structural changes similar to humans with Arnold-Chiari malformation, 
including downward displacement of the cerebellum to just above the foramen magnum and 
compression of the developing medulla into a small posterior fossa [266]. A recent MRI 
study has commented on the co-existence of Chiari malformation with some paediatric 
autism patients [267]. The targeting of the cerebellum by tretinoin is particularly relevant 
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given that cerebellar abnormalities are a consistent feature of autism [268-270]. The transfer 
of retinoic acid across pig skin is increased by exposure to particulate matter containing 
polycyclic aromatic hydrocarbons [271]. 
Brief details of some of the other high-scoring compounds are shown below. 
Acetovanillone inhibits the free radical superoxide generator NADPH oxidase [272] . The 
activity of this enzyme is decreased in granulocytes and lymphocytes of autistic children 
contributing to a spectrum of mitochondrial malfunction in these cases [273,274].   
Patchouli alcohol decreases cell growth in MCF7, BxPC3, PC3, and HUVEC cells and 
downregulates histone deacetylase HDAC2 in human colorectal cancer cells [275]. HDAC2 is 
a valproate target also forming a complex with the Rett syndrome gene MECP2 [276,277]. 
Limonene is an inhibitor of protein farnesyl transferase (FNTA FNTB) and protein 
geranylgeranyl transferase (PGGT1B) [278]. Farnesylation is essential for embryonic 
development [279] and Farnesyl and geranylphosphate play a role in angiogenesis in human 
umbilical endothelial cells [280,281].  Limonene is metabolised by cytochrome p5450’s 
CYP2C9 and CYP2C19 [282] both of which metabolise progesterone, while testosterone is a 
substrate for CYP2C19 [283]. 
Nonylphenol is a persistent endocrine disruptor used in home maintenance products that is 
also ubiquitous in foodstuffs for babies and toddlers commercially available in Germany 
[284] and in many other foods including human breast milk in Europe [285,286]. 
Nonylphenol and other compounds including dioxins, polychlorinated biphenyls, 
organochlorine pesticides, bisphenol A, and phytoestrogens have also been detected in 
umbilical cords and cord sera in Japan [287].  
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The role of these and many other compounds, alone or as mixtures more relevant to shelf 
products, in relation to autism remains to be further characterised. 
 Figure 11. The number of ASG’s affected by compounds in cosmetics (N ASG’s =left axis, 
p values =right axis). The enrichment ratio and the total number of genes affected by each 
compound are shown after each compound name. The presence of these compounds in food 
(F), the EAFUS list (E), nutraceuticals (N) or household products (H) is also indicated. a-
Tocopherol = alpha-Tocopherol; BHA= Butylated hydroxyanisole; DeNitros = 
Diethylnitrosamine ; PMP= phenylmethylpyrazolone; PIC= phenethyl isothiocyanate; TBHQ 
= 2-tert-butylhydroquinone. 
 
Compounds affecting barriers or respiratory cilia. 
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As previously reported [11], many of the autism genes in this set are involved in barrier 
functions across several different boundaries (blood/brain, skin, intestinal and placental) and 
also in the control of respiratory cilia that clear the airways of noxious particles. Evidently, 
environmental chemicals have to traverse such boundaries. In addition, some also have 
deleterious effects on barrier or cilia function.  
Several pesticides (malathion and lead acetate , Chlorpyrifos  or a combination of the insect 
repellent, DEET (N,N-Diethyl-meta-toluamide) and permethrin) are able to disrupt the blood 
brain barrier  in animal models [288] and nicotine and smoking disrupt brain 
microvasculature and the blood brain barrier[289]. Long-term air pollution in cities relates to 
neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, 
ultrafine particulate deposition, and accumulation of beta-amyloid in children and young 
adults  [290].   Air pollution also disrupts epithelial and endothelial barriers and triggers 
autoimmune responses involving tight junction and neural autoantibodies [291]. 
Nanoparticles from aluminium, silver or copper increase spinal cord pathology after trauma, 
an effect correlated with breakdown of the blood-spinal cord barrier [292]. NH4Cl increases 
the permeability of pial venular capillaries to Lucifer Yellow, as does histamine .[227]. The 
transfer of retinoic acid across pig skin is increased by exposure to particulate matter 
containing polycyclic aromatic hydrocarbons [271]. 
With regard to respiratory cilia, cigarette smoke decreases beat frequency and cilia length is 
reduced in healthy smokers. Long-term exposure to cigarette smoke leads to reduced 
numbers of ciliated cells in mice [293,294]. A combination of cigarette smoke and alcohol 
also decreases ciliary beat frequency in bovine primary ciliated bronchial epithelial cells 
[295]. Chlorocresol, a disinfectant, decreases ciliary beat frequency in human nasal epithelial 
cells [296] , and the insecticide deltamethrin provokes respiratory ciliary damage in rats [297] 
. The fungicide benomyl and its metabolites, butyl isocyanate and carbendazim, decrease 
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ciliary beat frequency in canine tracheal epithelial tissue [298] . Progesterone inhibits cilia 
beat frequency in human lung and cultured primary human airway epithelial cells, an effect 
inhibited by 17beta-estradiol [299]. No effects could be found in relation to endocrine 
disruptors, although they might be expected to exert effects in relation to those of these 
steroid hormones. Ciliary function is also compromised by vanadium, vanadium-rich oil-fired 
fly ash and cadmium [300,301]. As noted above, bitter taste receptors increase cilia function, 
and these are inhibited by sweet taste receptors activated by aspartame and glucose.   
Such deleterious effects are likely to modify the intake of many other compounds. 
 
Ecological pollution and bioaccumulation. 
Many compounds used in cosmetics or as food additives can be directly absorbed or ingested 
and pesticide sprays and volatile compounds inhaled.  While the concentrations of some may 
well be too low to elicit direct toxicity individually, a further problem relates to the disposal 
of multiple products down drains or in waste dumps from where they can seep into the air 
and water tables. For example, a recent study relating to fragrances in the Venice lagoon  
showed that the total concentrations of multiple ingredients , at different times, varied from ~ 
30ng/litre to > 10μg/litre  in polluted canals during low tide [302]. Such compounds can be 
concentrated by the food web (bioaccumulation). and contraceptive ingredients, drugs, 
pesticides , endocrine disruptors  and other pollutants have been found in marine 
invertebrates or in fish, at levels which have demonstrable effects on endocrine function 
[303-305]. Compounds in pesticide sprays, such as nonylphenol, can also travel long 
distances [306]. Such compounds exist in multiple permutations in relation to environmental 
contamination. The effects of the various compounds, as illustrated in the figures above, 
apply to individual compounds, but the real life situation involves multiple ingredients in 
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food or cosmetics and diverse mixtures of environmental pollutants with additive effects. The 
enrichment of autism genes in the effects of these compounds must therefore be viewed in 
this context. In an American study in 2011,  certain polychlorinated biphenyls, 
organochlorine pesticides, perfluorinated compounds, phenols, polybrominated diphenyl 
ethers (flame retardants), phthalates, polycyclic aromatic hydrocarbons, and perchlorate were 
detected in 99-100% of pregnant women [307].This ecological problem applies to 
agrochemical and industrial pollutants and likely to hundreds of biologically active 
compounds in food, cosmetic, drug and household products. Concerns about these products 
in relation to autism and other neurodevelopmental and cognitive disorders has recently been 
raised in The TENDR Consensus Statement, a call to action to reduce exposures to toxic 
chemicals [308].   
Caveats: There are numerous caveats. Firstly, this is a comparison of two lists of gene 
symbols, with no indication of weight (relative importance in relation to specific genes or 
processes) or directionality (i.e. does the compound activate or inhibit, or are the effects on 
binding, transcription or phosphorylation, etc.), although these can be found within CTD and 
in the literature for any interaction of interest. The question of dosage and timing is also 
important when comparing human and animal studies. However, the enrichment data and 
those of certain animal studies (For example the use of mixtures of endocrine disruptors 
[26,29]see Table 1) suggest that “overall toxicological burden” may be a more relevant 
comparison. This type of enrichment applies to toxicant chemicals, but also to those that 
might be beneficial (e.g. folic acid, lipoic acid, or glutathione), or a mixture of both (e.g. 
Oxytocin, where prenatal use is associated with risk and later use with benefit).In many 
cases, for example pesticides, heavy metals, bisphenol A, phthalates, valproate, etc.), a link to 
autism is supported by epidemiology and/or by animal studies in relation to development (see 
Table 1) . Related compounds not yet studied in autism, particularly atrazine and other 
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pesticides, blue asbestos or known endocrine disruptors can hardly be considered as benign. 
Other compounds, for example aspartame, titanium dioxide or sodium fluoride, do possess 
endocrine disrupting or other toxic effects relevant to neurodevelopment.    As stated on the 
CTD website, such data can be used for hypothesis testing. It is impossible to predict whether 
any uncharacterised compound plays a causal role in autism, but these data can at least 
provide a long list worthy of further investigation in epidemiological and animal studies.  
For all of the suspect compounds, replication in epidemiological and neurodevelopmental 
studies is essential to verify any causal effect in relation to autism. Meta-analysis studies 
support the involvement of particulate matter or ambient air pollution in relation to autism in 
North American [81,309] but not European studies [87] and for the prenatal uses of SSRI’s 
[310] or Vitamin D deficiency in autistic patients [311]  but the diverse methodologies used 
to measure timing and exposure have rendered clear conclusions difficult for these and others 
such as phthalate esters [312]. These problems are confounded by the gene/environment 
interactions raised in this study (i.e. compound X may contribute to autism but only in 
individuals with gene variants that allow it to do so). Environmental pollution also involves 
exposure to multiple airborne, ingested or contact toxins whose effects may be cumulative 
and where individual blame is difficult to dissect.     
Discussion 
The specific question posed by this type of analysis is not whether any compound affects 
autism genes/proteins, but whether it affects more autism genes than would be expected from 
the overall toxicological profile of that compound. If such is the case, one might assume that 
there is a particular relationship between genes and environment that suggests that the genetic 
polymorphisms, as well as disrupting key autism pathways related to pathology, also affect 
the ability of certain toxicants to exert their effects via the same genes or proteins. One might 
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therefore expect that many of these genes, also related to barrier function, modify the 
absorption, metabolism, excretion or physiological effects of the toxicants. In several cases, 
this has been shown to be the case, and certain autism polymorphisms do affect these 
parameters[3,11], although this has not been tested for all of the many genes or chemicals 
involved.    
In relation to these questions, several hundred compounds selectively target multiple 
members of this particular group of 206 genes. 6338 unidentified compounds in CTD did not 
affect any autism gene, while the effects of many others were not significant, showing a 
degree of specificity. Within this group of significant compounds are the majority of the 
compounds suspected to be implicated in autism including pesticides, heavy metals, and 
industrial pollutants, Bisphenol A and phthalates , flame retardants, and several drugs , 
fluoxetine and other SSRI’s, as well as acetaminophen, valproate and certain drugs used in 
labour. This exercise also returned all of the general classes of compounds suspected to be 
implicated in autism, including particulate matter and other components of diesel exhaust,   
polyhalogenated biphenyls, polycyclic aromatic hydrocarbons, persistent organic pollutants 
and endocrine disruptors. The endogenous hormones and transmitters targeting these genes 
are also highly relevant to endocrine disruption and to the key transmitters related to autism 
(retinoids, sex steroids, thyroxine, melatonin, folate, dopamine, and serotonin) and to the 
processes implicated in pathology (compounds related to oxidative stress, 
folate/methionine/homocysteine, inflammation or myelination). Many more compounds were 
identified, which due to the cumulative nature of many of these exposures, might also play a 
role. Overall, these data show that this type of enrichment analysis can identify key 
compounds reported to be involved in autism. Some of the other compounds also targeting 
the autism genes clearly possess relevant toxic effects, (e.g. other pesticides, titanium 
dioxide, tretinoin or aspartame). However, overall enrichment may reflect beneficial and 
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deleterious effects and such a list can really only suggest compounds worthy of consideration 
in epidemiological and toxicological studies, particularly during pregnancy and in relation to 
neurodevelopment and autism.  Given the multiplicity of compounds potentially involved, 
many with different solvent requirements and diverse assay techniques and sensitivities, it 
might also be useful to establish autism blood and tissue banks and research consortia along 
the lines now used in genome-wide studies, to adequately quantify such a large variety of 
chemicals.       
Many of these compounds are considered safe by government authorities, but no regulatory 
toxicological studies could have taken into account the possibility that toxicity might be 
determined by the same genes that govern susceptibility to autism. This problem could 
perhaps be addressed using a range of compounds and banked stem cells or tissues from 
autistic patients or their parents to analyse whether toxicant properties differ in autism cells. 
A large number of chemicals relate to many autism genes suggesting that the two act in 
concert and that the rise in the incidence of autism is likely to be chemically driven, in a 
gene-dependent manner. In this study relating chemicals or environment to genes, it seems 
that genes and environment are indissociable and that the susceptibility genes themselves 
may constitute one of the strongest arguments for a causal effect of the environment, as it is 
towards their products that multiple environmental influences are selectively directed, and via 
the agency of the gene products that the pathology must be induced, or the toxic products 
allowed to pass or act.  
There appears to be no known reason to suppose that the same genetic variants did not exist 
in the population prior to the autism epidemic, but a modified environment might have 
rendered them more relevant to autism. This is akin to the classical population genetics 
example of the peppered moth. The genes controlling its mottled colouring originally 
conferred protection from birds, due to camouflage on similarly marked tree bark. Such trees 
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were blackened by industrial soot pollution, and the same genes now conferred a high risk of 
predation  [313], a situation reversed by clean air acts in the UK and USA [314].   
The solution to autism prevention may thus similarly reside in the detection, avoidance and 
removal of the pollutants, a task involving the development of stricter and more appropriate 
toxicological and environmental controls at governmental level worldwide,  as already 
proposed in the recent TENDR Consensus Statement (Targeting Environmental Neuro-
Developmental Risks) [308].    
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
The authors report no conflicts of interest. 
 
 
 
 
 
 
 
 
 
 
62 
 
 
 
 
Reference List 
 
 [1]  Wingate M, Kirby RS, Pettygrove S, Cunniff C, Schulz E, Ghosh T, Robinson C (2014) Prevalence of 
autism spectrum disorder among children aged 8 years - autism and developmental disabilities 
monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 63, 1-21.  
 [2]  Taylor B, Jick H, Maclaughlin D (2013) Prevalence and incidence rates of autism in the UK: time trend 
from 2004-2010 in children aged 8 years. BMJ Open 3, e003219-  
 [3]  Rossignol DA, Genuis SJ, Frye RE (2014) Environmental toxicants and autism spectrum disorders: a 
systematic review. Transl Psychiatry 4, e360-  
 [4]  Sealey LA, Hughes BW, Sriskanda AN, Guest JR, Gibson AD, Johnson-Williams L, Pace DG, Bagasra 
O (2016) Environmental factors in the development of autism spectrum disorders. Environ Int 
88, 288-298.  
 [5]  D'Amelio M, Ricci I, Sacco R, Liu X, D'Agruma L, Muscarella LA, Guarnieri V, Militerni R, 
Bravaccio C, Elia M, Schneider C, Melmed R, Trillo S, Pascucci T, Puglisi-Allegra S, 
Reichelt KL, Macciardi F, Holden JJ, Persico AM (2005) Paraoxonase gene variants are 
associated with autism in North America, but not in Italy: possible regional specificity in 
gene-environment interactions. Mol Psychiatry 10, 1006-1016.  
 [6]  Birnbaum R, Jaffe AE, Hyde TM, Kleinman JE, Weinberger DR (2014) Prenatal Expression Patterns 
of Genes Associated With Neuropsychiatric Disorders. Am J Psychiatry  
 [7]  Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Bellanger M, 
Hauser R, Legler J, Skakkebaek NE, Heindel JJ (2015) Estimating burden and disease costs of 
exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab 
100, 1245-1255.  
 [8]  Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Hunt PM, Rudel 
R, Sathyanarayana S, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ (2016) 
Burden of disease and costs of exposure to endocrine disrupting chemicals in the European 
Union: an updated analysis. Andrology  
 [9]  Nelson TH, Jung JY, Deluca TF, Hinebaugh BK, St Gabriel KC, Wall DP (2012) Autworks: a cross-
disease network biology application for Autism and related disorders. BMC Med Genomics 5, 
56-  
 [10]  Wall DP, Pivovarov R, Tong M, Jung JY, Fusaro VA, Deluca TF, Tonellato PJ (2010) Genotator: a 
disease-agnostic tool for genetic annotation of disease. BMC Med Genomics 3, 50-  
 [11]  Carter CJ (2016) The barrier, airway particle clearance, placental and detoxification functions of autism 
susceptibility genes. Neurochem Int 99, 42-51.  
 [12]  Grayson DR , Guidotti A (2016) Merging data from genetic and epigenetic approaches to better 
understand autistic spectrum disorder. Epigenomics 8, 85-104.  
 [13]  LaSalle JM (2013) Epigenomic strategies at the interface of genetic and environmental risk factors for 
autism. J Hum Genet 58, 396-401.  
63 
 
 [14]  Kubota T , Mochizuki K (2016) Epigenetic Effect of Environmental Factors on Autism Spectrum 
Disorders. Int J Environ Res Public Health 13  
 [15]  Harlid S, Adgent M, Jefferson WN, Panduri V, Umbach DM, Xu Z, Stallings VA, Williams CJ, Rogan 
WJ, Taylor JA (2016) Soy Formula and Epigenetic Modifications: Analysis of Vaginal 
Epithelial Cells from Infant Girls in the IFED Study. Environ Health Perspect  
 [16]  Prusinski L, Al Hendy A, Yang Q (2016) Developmental exposure to endocrine disrupting chemicals 
alters the epigenome: Identification of reprogrammed targets. Gynecol Obstet Res 3, 1-6.  
 [17]  Hamza M, Halayem S, Mrad R, Bourgou S, Charfi F, Belhadj A (2016) Epigenetics' implication in 
autism spectrum disorders: A review. Encephale  
 [18]  Keil KP , Lein PJ (2016) DNA methylation: a mechanism linking environmental chemical exposures to 
risk of autism spectrum disorders? Environ Epigenet 2  
 [19]  Yu L, Wu Y, Wu BL (2015) Genetic architecture, epigenetic influence and environment exposure in 
the pathogenesis of Autism. Sci China Life Sci 58, 958-967.  
 [20]  Davis AP, Murphy CG, Johnson R, Lay JM, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King 
BL, Rosenstein MC, Wiegers TC, Mattingly CJ (2013) The Comparative Toxicogenomics 
Database: update 2013.  Nucleic Acids Res 41, D1104-D1114.  
 [21]  Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG, Cremer L, Hatchwell E (2006) Autism 
and environmental genomics. Neurotoxicology 27, 671-684.  
 [22]  Audouze K , Grandjean P (2011) Application of computational systems biology to explore 
environmental toxicity hazards.  Environ Health Perspect 119, 1754-1759.  
 [23]  Nishijo M, Pham TT, Nguyen AT, Tran NN, Nakagawa H, Hoang LV, Tran AH, Morikawa Y, Ho 
MD, Kido T, Nguyen MN, Nguyen HM, Nishijo H (2014) 2,3,7,8-Tetrachlorodibenzo-p-
dioxin in breast milk increases autistic traits of 3-year-old children in Vietnam. Mol 
Psychiatry  
 [24]  Tran NN, Pham TT, Ozawa K, Nishijo M, Nguyen AT, Tran TQ, Hoang LV, Tran AH, Phan VH, 
Nakai A, Nishino Y, Nishijo H (2016) Impacts of Perinatal Dioxin Exposure on Motor 
Coordination and Higher Cognitive Development in Vietnamese Preschool Children: A Five-
Year Follow-Up. PLoS One 11, e0147655-  
 [25]  Nowack N, Wittsiepe J, Kasper-Sonnenberg M, Wilhelm M, Scholmerich A (2015) Influence of Low-
Level Prenatal Exposure to PCDD/Fs and PCBs on Empathizing, Systemizing and Autistic 
Traits: Results from the Duisburg Birth Cohort Study. PLoS One 10, e0129906-  
 [26]  Sobolewski M, Conrad K, Allen JL, Weston H, Martin K, Lawrence BP, Cory-Slechta DA (2014) Sex-
specific enhanced behavioral toxicity induced by maternal exposure to a mixture of low dose 
endocrine-disrupting chemicals. Neurotoxicology 45, 121-130.  
 [27]  Pearson BL, Simon JM, McCoy ES, Salazar G, Fragola G, Zylka MJ (2016) Identification of chemicals 
that mimic transcriptional changes associated with autism, brain aging and neurodegeneration. 
Nat Commun 7, 11173-  
 [28]  Gunier RB, Bradman A, Harley KG, Kogut K, Eskenazi B (2016) Prenatal Residential Proximity to 
Agricultural Pesticide Use and IQ in 7-Year-Old Children. Environ Health Perspect  
 [29]  Lichtensteiger W, Bassetti-Gaille C, Faass O, Axelstad M, Boberg J, Christiansen S, Rehrauer H, 
Georgijevic JK, Hass U, Kortenkamp A, Schlumpf M (2015) Differential gene expression 
patterns in developing sexually dimorphic rat brain regions exposed to antiandrogenic, 
estrogenic, or complex endocrine disruptor mixtures: glutamatergic synapses as target. 
Endocrinology 156, 1477-1493.  
64 
 
 [30]  Lee I, Eriksson P, Fredriksson A, Buratovic S, Viberg H (2015) Developmental neurotoxic effects of 
two pesticides: Behavior and neuroprotein studies on endosulfan and cypermethrin. 
Toxicology 335, 1-10.  
 [31]  Caudle WM (2015) Vulnerability of synapses in the frontal cortex of mice developmentally exposed to 
an insecticide: Potential contribution to neuropsychiatric disease. Neurotransmitter (Houst ) 2  
 [32]  Braun JM, Kalkbrenner AE, Just AC, Yolton K, Calafat AM, Sjodin A, Hauser R, Webster GM, Chen 
A, Lanphear BP (2014) Gestational exposure to endocrine-disrupting chemicals and reciprocal 
social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study.  
Environ Health Perspect 122, 513-520.  
 [33]  Shelton JF, Geraghty EM, Tancredi DJ, Delwiche LD, Schmidt RJ, Ritz B, Hansen RL, Hertz-Picciotto 
I (2014) Neurodevelopmental Disorders and Prenatal Residential Proximity to Agricultural 
Pesticides: The CHARGE Study. Environ Health Perspect  
 [34]  De Felice A, Venerosi A, Ricceri L, Sabbioni M, Scattoni ML, Chiarotti F, Calamandrei G (2014) Sex-
dimorphic effects of gestational exposure to the organophosphate insecticide chlorpyrifos on 
social investigation in mice. Neurotoxicol Teratol 46, 32-39.  
 [35]  De Felice A, Scattoni ML, Ricceri L, Calamandrei G (2015) Prenatal exposure to a common 
organophosphate insecticide delays motor development in a mouse model of idiopathic 
autism. PLoS One 10, e0121663-  
 [36]  De Felice A, Greco A, Calamandrei G, Minghetti L (2016) Prenatal exposure to the organophosphate 
insecticide chlorpyrifos enhances brain oxidative stress and prostaglandin E2 synthesis in a 
mouse model of idiopathic autism. J Neuroinflammation 13, 149-  
 [37]  Domingues VF, Nasuti C, Piangerelli M, Correia-Sa L, Ghezzo A, Marini M, Abruzzo PM, Visconti P, 
Giustozzi M, Rossi G, Gabbianelli R (2016) Pyrethroid Pesticide Metabolite in Urine and 
Microelements in Hair of Children Affected by Autism Spectrum Disorders: A Preliminary 
Investigation. Int J Environ Res Public Health 13, 388-  
 [38]  Hill DS, Cabrera R, Wallis SD, Zhu H, Lu W, Finnell RH, Wlodarczyk BJ (2015) Autism-Like 
Behavior and Epigenetic Changes Associated with Autism as Consequences of In Utero 
Exposure to Environmental Pollutants in a Mouse Model. Behav Neurol 2015, 426263-  
 [39]  Blaurock-Busch E, Amin OR, Dessoki HH, Rabah T (2012) Toxic Metals and Essential Elements in 
Hair and Severity of Symptoms among Children with Autism. Maedica (Buchar ) 7, 38-48.  
 [40]  Blaurock-Busch E, Amin OR, Rabah T (2011) Heavy metals and trace elements in hair and urine of a 
sample of arab children with autistic spectrum disorder. Maedica (Buchar ) 6, 247-257.  
 [41]  Tomljenovic L , Shaw CA (2011) Do aluminum vaccine adjuvants contribute to the rising prevalence 
of autism? J Inorg Biochem 105, 1489-1499.  
 [42]  Nevison CD (2014) A comparison of temporal trends in United States autism prevalence to trends in 
suspected environmental factors. Environ Health 13, 73-  
 [43]  Shaw CA, Li Y, Tomljenovic L (2013) Administration of aluminium to neonatal mice in vaccine-
relevant amounts is associated with adverse long term neurological outcomes. J Inorg 
Biochem 128, 237-244.  
 [44]  Al Ayadhi LY (2005) Heavy metals and trace elements in hair samples of autistic children in central 
Saudi Arabia. Neurosciences (Riyadh ) 10, 213-218.  
 [45]  Dickerson AS, Rahbar MH, Han I, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Durkin M, 
Kirby RS, Wingate MS, Tian LH, Zahorodny WM, Pearson DA, Moye LA, III, Baio J (2015) 
Autism spectrum disorder prevalence and proximity to industrial facilities releasing arsenic, 
lead or mercury. Sci Total Environ 536, 245-251.  
65 
 
 [46]  Talbott EO, Marshall LP, Rager JR, Arena VC, Sharma RK, Stacy SL (2015) Air toxics and the risk of 
autism spectrum disorder: the results of a population based case-control study in southwestern 
Pennsylvania. Environ Health 14, 80-  
 [47]  Yorbik O, Kurt I, Hasimi A, Ozturk O (2010) Chromium, cadmium, and lead levels in urine of children 
with autism and typically developing controls. Biol Trace Elem Res 135, 10-15.  
 [48]  Li SO, Wang JL, Bjorklund G, Zhao WN, Yin CH (2014) Serum copper and zinc levels in individuals 
with autism spectrum disorders. Neuroreport 25, 1216-1220.  
 [49]  Bjorklund G (2013) The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp 
(Wars ) 73, 225-236.  
 [50]  Craciun EC, Bjorklund G, Tinkov AA, Urbina MA, Skalny AV, Rad F, Dronca E (2016) Evaluation of 
whole blood zinc and copper levels in children with autism spectrum disorder. Metab Brain 
Dis 31, 887-890.  
 [51]  Macedoni-Luksic M, Gosar D, Bjorklund G, Orazem J, Kodric J, Lesnik-Musek P, Zupancic M, 
France-Stiglic A, Sesek-Briski A, Neubauer D, Osredkar J (2015) Levels of metals in the 
blood and specific porphyrins in the urine in children with autism spectrum disorders. Biol 
Trace Elem Res 163, 2-10.  
 [52]  Baecker T, Mangus K, Pfaender S, Chhabra R, Boeckers TM, Grabrucker AM (2014) Loss of 
COMMD1 and copper overload disrupt zinc homeostasis and influence an autism-associated 
pathway at glutamatergic synapses. Biometals 27, 715-730.  
 [53]  Schmidt RJ, Tancredi DJ, Krakowiak P, Hansen RL, Ozonoff S (2014) Maternal intake of 
supplemental iron and risk of autism spectrum disorder. Am J Epidemiol 180, 890-900.  
 [54]  Sidrak S, Yoong T, Woolfenden S (2014) Iron deficiency in children with global developmental delay 
and autism spectrum disorder. J Paediatr Child Health 50, 356-361.  
 [55]  Chen MH, Su TP, Chen YS, Hsu JW, Huang KL, Chang WH, Chen TJ, Bai YM (2013) Association 
between psychiatric disorders and iron deficiency anemia among children and adolescents: a 
nationwide population-based study. BMC Psychiatry 13, 161-  
 [56]  Harvey L , Boksa P (2014) Additive effects of maternal iron deficiency and prenatal immune activation 
on adult behaviors in rat offspring. Brain Behav Immun 40, 27-37.  
 [57]  Dickerson AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Kirby RS, Durkin 
MS, Han I, Moye LA, III, Pearson DA, Wingate MS, Zahorodny WM (2016) Autism 
spectrum disorder prevalence and associations with air concentrations of lead, mercury, and 
arsenic. Environ Monit Assess 188, 407-  
 [58]  Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF, Koenen KC, Ascherio A, Weisskopf MG 
(2013) Perinatal air pollutant exposures and autism spectrum disorder in the children of 
Nurses' Health Study II participants. Environ Health Perspect 121, 978-984.  
 [59]  Rahbar MH, Samms-Vaughan M, Ma J, Bressler J, Dickerson AS, Hessabi M, Loveland KA, Grove 
ML, Shakespeare-Pellington S, Beecher C, McLaughlin W, Boerwinkle E (2015) Synergic 
effect of GSTP1 and blood manganese concentrations in Autism Spectrum Disorder. Res 
Autism Spectr Disord 18, 73-82.  
 [60]  McDermott S, Salzberg DC, Anderson AP, Shaw T, Lead J (2015) Systematic Review of Chromium 
and Nickel Exposure During Pregnancy and Impact on Child Outcomes. J Toxicol Environ 
Health A 78, 1348-1368.  
 [61]  Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell 
J, Atwood S, Barnhouse S, Lee W (2013) Toxicological status of children with autism vs. 
66 
 
neurotypical children and the association with autism severity. Biol Trace Elem Res 151, 171-
180.  
 [62]  Faber S, Zinn GM, Kern JC, Kingston HM (2009) The plasma zinc/serum copper ratio as a biomarker 
in children with autism spectrum disorders. Biomarkers 14, 171-180.  
 [63]  Macedoni-Luksic M, Gosar D, Bjorklund G, Orazem J, Kodric J, Lesnik-Musek P, Zupancic M, 
France-Stiglic A, Sesek-Briski A, Neubauer D, Osredkar J (2015) Levels of metals in the 
blood and specific porphyrins in the urine in children with autism spectrum disorders. Biol 
Trace Elem Res 163, 2-10.  
 [64]  Yasuda H, Yoshida K, Yasuda Y, Tsutsui T (2011) Infantile zinc deficiency: association with autism 
spectrum disorders.  Sci Rep 1, 129-  
 [65]  Lee EJ, Lee H, Huang TN, Chung C, Shin W, Kim K, Koh JY, Hsueh YP, Kim E (2015) Trans-
synaptic zinc mobilization improves social interaction in two mouse models of autism through 
NMDAR activation. Nat Commun 6, 7168-  
 [66]  Kirsten TB, Queiroz-Hazarbassanov N, Bernardi MM, Felicio LF (2015) Prenatal zinc prevents 
communication impairments and BDNF disturbance in a rat model of autism induced by 
prenatal lipopolysaccharide exposure. Life Sci 130, 12-17.  
 [67]  von Ehrenstein OS, Aralis H, Cockburn M, Ritz B (2014) In Utero Exposure to Toxic Air Pollutants 
and Risk of Childhood Autism. Epidemiology  
 [68]  Thirtamara RK, Doherty-Lyons S, Bolden C, Willis D, Hoffman C, Zelikoff J, Chen LC, Gu H (2013) 
Prenatal and early-life exposure to high-level diesel exhaust particles leads to increased 
locomotor activity and repetitive behaviors in mice. Autism Res  6, 248-257.  
 [69]  Costa LG, Cole TB, Coburn J, Chang YC, Dao K, Roque PJ (2015) Neurotoxicity of traffic-related air 
pollution. Neurotoxicology  
 [70]  Kalkbrenner AE, Schmidt RJ, Penlesky AC (2014) Environmental Chemical Exposures and Autism 
Spectrum Disorders: A Review of the Epidemiological Evidence. Curr Probl Pediatr Adolesc 
Health Care  
 [71]  De Alwis D, Agrawal A, Reiersen AM, Constantino JN, Henders A, Martin NG, Lynskey MT (2014) 
ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins. J 
Stud Alcohol Drugs 75, 211-221.  
 [72]  Duan G, Chen J, Yao M, Ma Y, Zhang W (2014) Perinatal and background risk factors for childhood 
autism in central China. Psychiatry Res  
 [73]  Hultman CM, Sparen P, Cnattingius S (2002) Perinatal risk factors for infantile autism. Epidemiology 
13, 417-423.  
 [74]  Indredavik MS, Brubakk AM, Romundstad P, Vik T (2007) Prenatal smoking exposure and psychiatric 
symptoms in adolescence. Acta Paediatr 96, 377-382.  
 [75]  St Pourcain B, Mandy WP, Heron J, Golding J, Davey SG, Skuse DH (2011) Links between co-
occurring social-communication and hyperactive-inattentive trait trajectories. J Am Acad 
Child Adolesc Psychiatry 50, 892-902.  
 [76]  Bejerot S , Nylander L (2003) Low prevalence of smoking in patients with autism spectrum disorders. 
Psychiatry Res 119, 177-182.  
 [77]  Becerra TA, Wilhelm M, Olsen J, Cockburn M, Ritz B (2013) Ambient air pollution and autism in Los 
Angeles county, California. Environ Health Perspect 121, 380-386.  
67 
 
 [78]  Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R (2013) Traffic-related air pollution, 
particulate matter, and autism. JAMA Psychiatry 70, 71-77.  
 [79]  Jung CR, Lin YT, Hwang BF (2013) Air pollution and newly diagnostic autism spectrum disorders: a 
population-based cohort study in Taiwan. PLoS One 8, e75510-  
 [80]  Fluegge K (2016) Does environmental exposure to the greenhouse gas, N2O, contribute to etiological 
factors in neurodevelopmental disorders? A mini-review of the evidence. Environ Toxicol 
Pharmacol 47, 6-18.  
 [81]  Flores-Pajot MC, Ofner M, Do MT, Lavigne E, Villeneuve PJ (2016) Childhood autism spectrum 
disorders and exposure to nitrogen dioxide, and particulate matter air pollution: A review and 
meta-analysis. Environ Res  
 [82]  Suades-Gonzalez E, Gascon M, Guxens M, Sunyer J (2015) Air Pollution and Neuropsychological 
Development: A Review of the Latest Evidence. Endocrinology 156, 3473-3482.  
 [83]  Raz R, Roberts AL, Lyall K, Hart JE, Just AC, Laden F, Weisskopf MG (2015) Autism spectrum 
disorder and particulate matter air pollution before, during, and after pregnancy: a nested case-
control analysis within the Nurses' Health Study II Cohort. Environ Health Perspect 123, 264-
270.  
 [84]  Kalkbrenner AE, Windham GC, Serre ML, Akita Y, Wang X, Hoffman K, Thayer BP, Daniels JL 
(2015) Particulate matter exposure, prenatal and postnatal windows of susceptibility, and 
autism spectrum disorders. Epidemiology 26, 30-42.  
 [85]  Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB (2014) Autism spectrum 
disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. 
Epidemiology 25, 44-47.  
 [86]  Gong T, Dalman C, Wicks S, Dal H, Magnusson C, Lundholm C, Almqvist C, Pershagen G (2016) 
Perinatal Exposure to Traffic-Related Air Pollution and Autism Spectrum Disorders. Environ 
Health Perspect  
 [87]  Guxens M, Ghassabian A, Gong T, Garcia-Esteban R, Porta D, Giorgis-Allemand L, Almqvist C, 
Aranbarri A, Beelen R, Badaloni C, Cesaroni G, de Nazelle A, Estarlich M, Forastiere F, 
Forns J, Gehring U, Ibarluzea J, Jaddoe VW, Korek M, Lichtenstein P, Nieuwenhuijsen MJ, 
Rebagliato M, Slama R, Tiemeier H, Verhulst FC, Volk HE, Pershagen G, Brunekreef B, 
Sunyer J (2016) Air Pollution Exposure during Pregnancy and Childhood Autistic Traits in 
Four European Population-Based Cohort Studies: The ESCAPE Project. Environ Health 
Perspect 124, 133-140.  
 [88]  Allen JL, Liu X, Pelkowski S, Palmer B, Conrad K, Oberdorster G, Weston D, Mayer-Proschel M, 
Cory-Slechta DA (2014) Early postnatal exposure to ultrafine particulate matter air pollution: 
persistent ventriculomegaly, neurochemical disruption, and glial activation preferentially in 
male mice. Environ Health Perspect 122, 939-945.  
 [89]  Allen JL, Oberdorster G, Morris-Schaffer K, Wong C, Klocke C, Sobolewski M, Conrad K, Mayer-
Proschel M, Cory-Slechta DA (2015) Developmental neurotoxicity of inhaled ambient 
ultrafine particle air pollution: Parallels with neuropathological and behavioral features of 
autism and other neurodevelopmental disorders. Neurotoxicology  
 [90]  Nilsen RM, Suren P, Gunnes N, Alsaker ER, Bresnahan M, Hirtz D, Hornig M, Lie KK, Lipkin WI, 
Reichborn-Kjennerud T, Roth C, Schjolberg S, Smith GD, Susser E, Vollset SE, Oyen AS, 
Magnus P, Stoltenberg C (2013) Analysis of self-selection bias in a population-based cohort 
study of autism spectrum disorders. Paediatr Perinat Epidemiol 27, 553-563.  
 [91]  Kalkbrenner AE, Braun JM, Durkin MS, Maenner MJ, Cunniff C, Lee LC, Pettygrove S, Nicholas JS, 
Daniels JL (2012) Maternal smoking during pregnancy and the prevalence of autism spectrum 
68 
 
disorders, using data from the autism and developmental disabilities monitoring network. 
Environ Health Perspect 120, 1042-1048.  
 [92]  Lyall K, Schmidt RJ, Hertz-Picciotto I (2014) Maternal lifestyle and environmental risk factors for 
autism spectrum disorders. Int J Epidemiol 43, 443-464.  
 [93]  Tran PL, Lehti V, Lampi KM, Helenius H, Suominen A, Gissler M, Brown AS, Sourander A (2013) 
Smoking during pregnancy and risk of autism spectrum disorder in a Finnish National Birth 
Cohort. Paediatr Perinat Epidemiol 27, 266-274.  
 [94]  Lee BK, Gardner RM, Dal H, Svensson A, Galanti MR, Rai D, Dalman C, Magnusson C (2012) Brief 
report: maternal smoking during pregnancy and autism spectrum disorders. J Autism Dev 
Disord 42, 2000-2005.  
 [95]  Jiang H, Liu L, Sun DL, Yin XN, Chen ZD, Wu CA, Chen WQ (2016) Interaction between passive 
smoking and folic acid supplement during pregnancy on autism spectrum disorder behaviors 
in children aged 3 years. Zhonghua Liu Xing Bing Xue Za Zhi 37, 940-944.  
 [96]  McCanlies EC, Fekedulegn D, Mnatsakanova A, Burchfiel CM, Sanderson WT, Charles LE, Hertz-
Picciotto I (2012) Parental occupational exposures and autism spectrum disorder. J Autism 
Dev Disord 42, 2323-2334.  
 [97]  Stein TP, Schluter MD, Steer RA, Guo L, Ming X (2015) Bisphenol A Exposure in Children With 
Autism Spectrum Disorders.  Autism Res 8, 272-283.  
 [98]  Kardas F, Bayram AK, Demirci E, Akin L, Ozmen S, Kendirci M, Canpolat M, Oztop DB, Narin F, 
Gumus H, Kumandas S, Per H (2016) Increased Serum Phthalates (MEHP, DEHP) and 
Bisphenol A Concentrations in Children With Autism Spectrum Disorder: The Role of 
Endocrine Disruptors in Autism Etiopathogenesis. J Child Neurol 31 , 629-635.  
 [99]  Sadowski RN, Wise LM, Park PY, Schantz SL, Juraska JM (2014) Early exposure to bisphenol A 
alters neuron and glia number in the rat prefrontal cortex of adult males, but not females. 
Neuroscience 279C, 122-131.  
 [100]  Wolstenholme JT, Taylor JA, Shetty SR, Edwards M, Connelly JJ, Rissman EF (2011) Gestational 
exposure to low dose bisphenol A alters social behavior in juvenile mice. PLoS One 6, 
e25448-  
 [101]  Wolstenholme JT, Edwards M, Shetty SR, Gatewood JD, Taylor JA, Rissman EF, Connelly JJ (2012) 
Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene 
expression. Endocrinology 153, 3828-3838.  
 [102]  Wolstenholme JT, Goldsby JA, Rissman EF (2013) Transgenerational effects of prenatal bisphenol A 
on social recognition. Horm Behav 64, 833-839.  
 [103]  Larsson M, Weiss B, Janson S, Sundell J, Bornehag CG (2009) Associations between indoor 
environmental factors and parental-reported autistic spectrum disorders in children 6-8 years 
of age. Neurotoxicology 30, 822-831.  
 [104]  Philippat C, Bennett DH, Krakowiak P, Rose M, Hwang HM, Hertz-Picciotto I (2015) Phthalate 
concentrations in house dust in relation to autism spectrum disorder and developmental delay 
in the CHildhood Autism Risks from Genetics and the Environment (CHARGE) study. 
Environ Health 14, 56-  
 [105]  Testa C, Nuti F, Hayek J, De Felice C, Chelli M, Rovero P, Latini G, Papini AM (2012) Di-(2-
ethylhexyl) phthalate and autism spectrum disorders. ASN Neuro 4, 223-229.  
 [106]  Stein TP, Schluter MD, Steer RA, Ming X (2013) Autism and phthalate metabolite glucuronidation. J 
Autism Dev Disord 43, 2677-2685.  
69 
 
 [107]  Lyall K, Croen LA, Sjodin A, Yoshida CK, Zerbo O, Kharrazi M, Windham GC (2016) 
Polychlorinated Biphenyl and Organochlorine Pesticide Concentrations in Maternal Mid-
Pregnancy Serum Samples: Association with Autism Spectrum Disorder and Intellectual 
Disability. Environ Health Perspect  
 [108]  Jolous-Jamshidi B, Cromwell HC, McFarland AM, Meserve LA (2010) Perinatal exposure to 
polychlorinated biphenyls alters social behaviors in rats. Toxicol Lett 199, 136-143.  
 [109]  Wayman GA, Bose DD, Yang D, Lesiak A, Bruun D, Impey S, Ledoux V, Pessah IN, Lein PJ (2012) 
PCB-95 modulates the calcium-dependent signaling pathway responsible for activity-
dependent dendritic growth. Environ Health Perspect 120, 1003-1009.  
 [110]  Kimura-Kuroda J, Nagata I, Kuroda Y (2007) Disrupting effects of hydroxy-polychlorinated biphenyl 
(PCB) congeners on neuronal development of cerebellar Purkinje cells: a possible causal 
factor for developmental brain disorders? Chemosphere 67, S412-S420.  
 [111]  Woods R, Vallero RO, Golub MS, Suarez JK, Ta TA, Yasui DH, Chi LH, Kostyniak PJ, Pessah IN, 
Berman RF, LaSalle JM (2012) Long-lived epigenetic interactions between perinatal PBDE 
exposure and Mecp2308 mutation. Hum Mol Genet 21, 2399-2411.  
 [112]  Napoli E, Hung C, Wong S, Giulivi C (2013) Toxicity of the flame-retardant BDE-49 on brain 
mitochondria and neuronal progenitor striatal cells enhanced by a PTEN-deficient 
background. Toxicol Sci 132, 196-210.  
 [113]  Westmark CJ (2013) Soy Infant Formula may be Associated with Autistic Behaviors. Autism Open 
Access 3  
 [114]  Sheng L, Ding X, Ferguson M, McCallister M, Rhoades R, Maguire M, Ramesh A, Aschner M, 
Campbell D, Levitt P, Hood DB (2010) Prenatal polycyclic aromatic hydrocarbon exposure 
leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol Sci 
118, 625-634.  
 [115]  Bauer AZ , Kriebel D (2013) Prenatal and perinatal analgesic exposure and autism: an ecological link. 
Environ Health 12, 41-  
 [116]  Schultz ST, Klonoff-Cohen HS, Wingard DL, Akshoomoff NA, Macera CA, Ji M (2008) 
Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: 
the results of a parent survey. Autism 12, 293-307.  
 [117]  Avella-Garcia CB, Julvez J, Fortuny J, Rebordosa C, Garcia-Esteban R, Galan IR, Tardon A, 
Rodriguez-Bernal CL, Iniguez C, Andiarena A, Santa-Marina L, Sunyer J (2016) 
Acetaminophen use in pregnancy and neurodevelopment: attention function and autism 
spectrum symptoms. Int J Epidemiol  
 [118]  Atladottir HO, Henriksen TB, Schendel DE, Parner ET (2012) Autism after infection, febrile episodes, 
and antibiotic use during pregnancy: an exploratory study. Pediatrics 130, e1447-e1454.  
 [119]  Li Q , Zhou JM (2016) The microbiota-gut-brain axis and its potential therapeutic role in autism 
spectrum disorder. Neuroscience 324, 131-139.  
 [120]  Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I (2014) Prenatal SSRI Use and 
Offspring With Autism Spectrum Disorder or Developmental Delay. Pediatrics  
 [121]  Beherec L, Quilici G, Rosier A, Gerardin P, Campion D, Guillin O (2014) Pharmacological treatments 
in patients with pervasive developmental disorders: A review. Encephale 40, 188-196.  
 [122]  Kaushik G, Xia Y, Yang L, Thomas MA (2016) Psychoactive pharmaceuticals at environmental 
concentrations induce in vitro gene expression associated with neurological disorders. BMC 
Genomics 17 Suppl 3, 435-  
70 
 
 [123]  Zimmerberg B , Germeyan SC (2015) Effects of neonatal fluoxetine exposure on behavior across 
development in rats selectively bred for an infantile affective trait. Dev Psychobiol 57, 141-
152.  
 [124]  Croen LA, Connors SL, Matevia M, Qian Y, Newschaffer C, Zimmerman AW (2011) Prenatal 
exposure to beta2-adrenergic receptor agonists and risk of autism spectrum disorders. J 
Neurodev Disord 3, 307-315.  
 [125]  Bercum FM, Rodgers KM, Benison AM, Smith ZZ, Taylor J, Kornreich E, Grabenstatter HL, Dudek 
FE, Barth DS (2015) Maternal Stress Combined with Terbutaline Leads to Comorbid Autistic-
Like Behavior and Epilepsy in a Rat Model. J Neurosci 35 , 15894-15902.  
 [126]  Zerrate MC, Pletnikov M, Connors SL, Vargas DL, Seidler FJ, Zimmerman AW, Slotkin TA, Pardo 
CA (2007) Neuroinflammation and behavioral abnormalities after neonatal terbutaline 
treatment in rats: implications for autism. J Pharmacol Exp Ther 322, 16-22.  
 [127]  Gregory SG, Anthopolos R, Osgood CE, Grotegut CA, Miranda ML (2013) Association of autism with 
induced or augmented childbirth in North Carolina Birth Record (1990-1998) and Education 
Research (1997-2007) databases. JAMA Pediatr 167, 959-966.  
 [128]  Ooi YP, Weng SJ, Kossowsky J, Gerger H, Sung M (2016) Oxytocin and Autism Spectrum Disorders: 
A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 
Pharmacopsychiatry  
 [129]  Penagarikano O (2016) Oxytocin in Animal Models of Autism Spectrum Disorder. Dev Neurobiol  
 [130]  Teng BL, Nonneman RJ, Agster KL, Nikolova VD, Davis TT, Riddick NV, Baker LK, Pedersen CA, 
Jarstfer MB, Moy SS (2013) Prosocial effects of oxytocin in two mouse models of autism 
spectrum disorders.  Neuropharmacology 72, 187-196.  
 [131]  Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, Capurro V, Finardi A, Donzelli A, Pattini L, 
Rubino T, Parolaro D, Nishimori K, Parenti M, Chini B (2011) Pharmacologic rescue of 
impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility 
in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry 69, 875-
882.  
 [132]  Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX (2015) Autistic children exhibit decreased 
levels of essential Fatty acids in red blood cells. Int J Mol Sci 16, 10061-10076.  
 [133]  Dean SL, Knutson JF, Krebs-Kraft DL, McCarthy MM (2012) Prostaglandin E2 is an endogenous 
modulator of cerebellar development and complex behavior during a sensitive postnatal 
period. Eur J Neurosci 35, 1218-1229.  
 [134]  Miller MT, Stromland K, Ventura L, Johansson M, Bandim JM, Gillberg C (2004) Autism with 
ophthalmologic malformations: the plot thickens. Trans Am Ophthalmol Soc 102, 107-120.  
 [135]  Ornoy A, Weinstein-Fudim L, Ergaz Z (2015) Prenatal factors associated with autism spectrum 
disorder (ASD). Reprod Toxicol 56, 155-169.  
 [136]  Stromland K, Nordin V, Miller M, Akerstrom B, Gillberg C (1994) Autism in thalidomide 
embryopathy: a population study. Dev Med Child Neurol 36, 351-356.  
 [137]  Narita M, Oyabu A, Imura Y, Kamada N, Yokoyama T, Tano K, Uchida A, Narita N (2010) 
Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-
induced autism model rat. Neurosci Res 66, 2-6.  
 [138]  Miyazaki K, Narita N, Narita M (2005) Maternal administration of thalidomide or valproic acid causes 
abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int J 
Dev Neurosci 23, 287-297.  
71 
 
 [139]  Christensen J, Gronborg TK, Sorensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M 
(2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood 
autism. JAMA 309, 1696-1703.  
 [140]  Gentile S (2014) Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate 
monotherapy: a systematic review with regulatory repercussions. CNS Spectr 19, 305-315.  
 [141]  Roullet FI, Lai JK, Foster JA (2013) In utero exposure to valproic acid and autism--a current review of 
clinical and animal studies. Neurotoxicol Teratol 36, 47-56.  
 [142]  Davis E, Fennoy I, Laraque D, Kanem N, Brown G, Mitchell J (1992) Autism and developmental 
abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc 84, 315-319.  
 [143]  Cook EH (1990) Autism: review of neurochemical investigation. Synapse 6, 292-308.  
 [144]  McArthur S, Pienaar IS, Siddiqi SM, Gillies GE (2016) Sex-specific disruption of murine midbrain 
astrocytic and dopaminergic developmental trajectories following antenatal GC treatment. 
Brain Struct Funct 221, 2459-2475.  
 [145]  Dufour-Rainfray D, Vourc'h P, Tourlet S, Guilloteau D, Chalon S, Andres CR (2011) Fetal exposure to 
teratogens: evidence of genes involved in autism. Neurosci Biobehav Rev 35, 1254-1265.  
 [146]  Wells PG, Bhatia S, Drake DM, Miller-Pinsler L (2016) Fetal oxidative stress mechanisms of 
neurodevelopmental deficits and exacerbation by ethanol and methamphetamine. Birth 
Defects Res C Embryo Today 108, 108-130.  
 [147]  Stein MT, Drahota A, Chavira DA (2008) Ian: a 7-year old with prenatal drug exposure and early 
exposure to family violence. J Dev Behav Pediatr 29, 512-515.  
 [148]  Oliveros JC (2007) VENNY. An interactive tool for comparing lists with Venn Diagrams. 
http://bioinfogp cnb csic es/tools/venny/index html  
 [149]  Rodgman A (2011) Problems with the Tobacco Products Scientific Advisory Committee (TPSAC) List 
of Harmful or Potentially Harmful Tobacco and/or Tobacco Smoke Components. Beiträge zur 
Tabakforschung International/Contributions to Tobacco Research 24, 1-19.  
 [150]  National Research Council (US) Steering Committee on Identification of Toxic and Potentially Toxic 
Chemicals for Consideration by the National Toxicology Program. (1984) Toxicity Testing: 
Strategies to Determine Needs and Priorities.,  National Academies Press (US); Washington 
D.C. 
 [151]  Benjamini Y , Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful 
Approach to Multiple Testing. Journal of the Royal Statistical Society Series B 
(Methodological) 57, 289-300.  
 [152]  Bigham M , Copes R (2005) Thiomersal in vaccines: balancing the risk of adverse effects with the risk 
of vaccine-preventable disease. Drug Saf 28, 89-101.  
 [153]  Taylor LE, Swerdfeger AL, Eslick GD (2014) Vaccines are not associated with autism: an evidence-
based meta-analysis of case-control and cohort studies. Vaccine 32, 3623-3629.  
 [154]  Yoshimasu K, Kiyohara C, Takemura S, Nakai K (2014) A meta-analysis of the evidence on the impact 
of prenatal and early infancy exposures to mercury on autism and attention 
deficit/hyperactivity disorder in the childhood. Neurotoxicology 44, 121-131.  
 [155]  Golos A , Lutynska A (2015) Thiomersal-containing vaccines - a review of the current state of 
knowledge. Przegl Epidemiol 69, 59-61.  
72 
 
 [156]  Kaushik G, Thomas MA, Aho KA (2015) Psychoactive pharmaceuticals as environmental 
contaminants may disrupt highly inter-connected nodes in an Autism-associated protein-
protein interaction network. BMC Bioinformatics 16 Suppl 7, S3-  
 [157]  Maggioni S, Bagnati R, Pandelova M, Schramm KW, Benfenati E (2013) Genistein and dicarboximide 
fungicides in infant formulae from the EU market. Food Chem 136, 116-119.  
 [158]  Behr M, Oehlmann J, Wagner M (2011) Estrogens in the daily diet: in vitro analysis indicates that 
estrogenic activity is omnipresent in foodstuff and infant formula. Food Chem Toxicol 49, 
2681-2688.  
 [159]  Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis J, Rieu D, Rigo J, Shamir R, 
Szajewska H, Turck D (2006) Soy protein infant formulae and follow-on formulae: a 
commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 42, 
352-361.  
 [160]  Borriello A, Bencivenga D, Caldarelli I, Tramontano A, Borgia A, Zappia V, Della RF (2014) 
Resveratrol: from basic studies to bedside. Cancer Treat Res 159, 167-184.  
 [161]  Hwang KA , Choi KC (2015) Anticarcinogenic Effects of Dietary Phytoestrogens and Their 
Chemopreventive Mechanisms. Nutr Cancer 67, 796-803.  
 [162]  Liu HX, Wang Y, Lu Q, Yang MZ, Fan GW, Karas RH, Gao XM, Zhu Y (2016) Bidirectional 
regulation of angiogenesis by phytoestrogens through estrogen receptor-mediated signaling 
networks. Chin J Nat Med 14, 241-254.  
 [163]  Belcher SM , Zsarnovszky A (2001) Estrogenic actions in the brain: estrogen, phytoestrogens, and 
rapid intracellular signaling mechanisms. J Pharmacol Exp Ther 299, 408-414.  
 [164]  Pearce EN , Braverman LE (2009) Environmental pollutants and the thyroid. Best Pract Res Clin 
Endocrinol Metab 23, 801-813.  
 [165]  Rebuli ME , Patisaul HB (2016) Assessment of sex specific endocrine disrupting effects in the prenatal 
and pre-pubertal rodent brain. J Steroid Biochem Mol Biol 160, 148-159.  
 [166]  Taliou A, Zintzaras E, Lykouras L, Francis K (2013) An open-label pilot study of a formulation 
containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children 
with autism spectrum disorders. Clin Ther 35, 592-602.  
 [167]  Jefferson WN, Padilla-Banks E, Goulding EH, Lao SP, Newbold RR, Williams CJ (2009) Neonatal 
exposure to genistein disrupts ability of female mouse reproductive tract to support 
preimplantation embryo development and implantation. Biol Reprod 80, 425-431.  
 [168]  Kong D, Xing L, Liu R, Jiang J, Wang W, Shang L, Wei X, Hao W (2013) Individual and combined 
developmental toxicity assessment of bisphenol A and genistein using the embryonic stem cell 
test in vitro. Food Chem Toxicol 60, 497-505.  
 [169]  Xing L, Xu Y, Xiao Y, Shang L, Liu R, Wei X, Jiang J, Hao W (2010) Embryotoxic and teratogenic 
effects of the combination of bisphenol A and genistein on in vitro cultured postimplantation 
rat embryos. Toxicol Sci 115, 577-588.  
 [170]  Yu C, Tai F, Zeng S, Zhang X (2013) Effects of perinatal daidzein exposure on subsequent behavior 
and central estrogen receptor alpha expression in the adult male mouse. Prog 
Neuropsychopharmacol Biol Psychiatry 43, 157-167.  
 [171]  Rodriguez-Gomez A, Filice F, Gotti S, Panzica G (2014) Perinatal exposure to genistein affects the 
normal development of anxiety and aggressive behaviors and nitric oxide system in CD1 male 
mice. Physiol Behav 133, 107-114.  
73 
 
 [172]  Jarrell J, Foster WG, Kinniburgh DW (2012) Phytoestrogens in human pregnancy. Obstet Gynecol Int 
2012, 850313-  
 [173]  de Cock M, Maas YG, van de BM (2012) Does perinatal exposure to endocrine disruptors induce 
autism spectrum and attention deficit hyperactivity disorders? Review. Acta Paediatr 101, 
811-818.  
 [174]  Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, Jaafari N, Schischmanoff O, 
Fagard R, Lagdas E, Kermarrec S, Ribardiere S, Botbol M, Fougerou C, Bronsard G, Vernay-
Leconte J (2013) Advances in the research of melatonin in autism spectrum disorders: 
literature review and new perspectives. Int J Mol Sci 14, 20508-20542.  
 [175]  Kajta M , Wojtowicz AK (2013) Impact of endocrine-disrupting chemicals on neural development and 
the onset of neurological disorders. Pharmacol Rep 65, 1632-1639.  
 [176]  Mazahery H, Camargo CA, Conlon C, Beck KL, Kruger MC, von Hurst PR (2016) Vitamin D and 
Autism Spectrum Disorder: A Literature Review. Nutrients 8  
 [177]  Roman GC, Ghassabian A, Bongers-Schokking JJ, Jaddoe VW, Hofman A, de Rijke YB, Verhulst FC, 
Tiemeier H (2013) Association of gestational maternal hypothyroxinemia and increased 
autism risk. Ann Neurol 74, 733-742.  
 [178]  Quaak I, Brouns MR, van de BM (2013) The dynamics of autism spectrum disorders: how neurotoxic 
compounds and neurotransmitters interact. Int J Environ Res Public Health 10, 3384-3408.  
 [179]  Tostes MH, Teixeira HC, Gattaz WF, Brandao MA, Raposo NR (2012) Altered neurotrophin, 
neuropeptide, cytokines and nitric oxide levels in autism. Pharmacopsychiatry 45, 241-243.  
 [180]  Coelho RP, Saini HS, Sato-Bigbee C (2010) Sphingosine-1-phosphate and oligodendrocytes: from cell 
development to the treatment of multiple sclerosis. Prostaglandins Other Lipid Mediat 91, 
139-144.  
 [181]  Wang H, Liang S, Wang M, Gao J, Sun C, Wang J, Xia W, Wu S, Sumner SJ, Zhang F, Sun C, Wu L 
(2016) Potential serum biomarkers from a metabolomics study of autism. J Psychiatry 
Neurosci 41, 27-37.  
 [182]  Lefevre A , Sirigu A (2016) The two fold role of oxytocin in social developmental disorders: A cause 
and a remedy? Neurosci Biobehav Rev 63, 168-176.  
 [183]  Henry EC, Bemis JC, Henry O, Kende AS, Gasiewicz TA (2006) A potential endogenous ligand for 
the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch Biochem 
Biophys 450, 67-77.  
 [184]  Barouki R, Aggerbeck M, Aggerbeck L, Coumoul X (2012) The aryl hydrocarbon receptor system. 
Drug Metabol Drug Interact 27, 3-8.  
 [185]  Stejskalova L , Pavek P (2011) The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl 
hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol 12, 715-730.  
 [186]  Shanle EK , Xu W (2011) Endocrine disrupting chemicals targeting estrogen receptor signaling: 
identification and mechanisms of action. Chem Res Toxicol 24, 6-19.  
 [187]  Zhou H, Wu H, Liao C, Diao X, Zhen J, Chen L, Xue Q (2010) Toxicology mechanism of the 
persistent organic pollutants (POPs) in fish through AhR pathway. Toxicol Mech Methods 20, 
279-286.  
 [188]  Swedenborg E, Ruegg J, Makela S, Pongratz I (2009) Endocrine disruptive chemicals: mechanisms of 
action and involvement in metabolic disorders. J Mol Endocrinol 43, 1-10.  
74 
 
 [189]  Belkacemi L, Bedard I, Simoneau L, Lafond J (2005) Calcium channels, transporters and exchangers in 
placenta: a review. Cell Calcium 37, 1-8.  
 [190]  Bernucci L, Henriquez M, Diaz P, Riquelme G (2006) Diverse calcium channel types are present in the 
human placental syncytiotrophoblast basal membrane. Placenta 27, 1082-1095.  
 [191]  Atchison WD (2003) Effects of toxic environmental contaminants on voltage-gated calcium channel 
function: from past to present. J Bioenerg Biomembr 35, 507-532.  
 [192]  Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, Przegalinski E, Pera J, Filip M (2015) 
Oxidative stress as an etiological factor and a potential treatment target of psychiatric 
disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep 67, 569-580.  
 [193]  Castro K, Klein LD, Baronio D, Gottfried C, Riesgo R, Perry IS (2014) Folic acid and autism: What do 
we know? Nutr Neurosci  
 [194]  Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla BB, Bonassi S (2012) Oxidative stress-
related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med 52, 
2128-2141.  
 [195]  Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tassone F, 
Hertz-Picciotto I (2012) Maternal periconceptional folic acid intake and risk of autism 
spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from 
Genetics and Environment) case-control study. Am J Clin Nutr 96, 80-89.  
 [196]  Wang H (2014) Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in 
autism spectrum disorders. Front Behav Neurosci 8, 104-  
 [197]  Jira P (2013) Cholesterol metabolism deficiency. Handb Clin Neurol 113, 1845-1850.  
 [198]  Schengrund CL, Ali-Rahmani F, Ramer JC (2012) Cholesterol, GM1, and autism. Neurochem Res  37, 
1201-1207.  
 [199]  Aneja A , Tierney E (2008) Autism: the role of cholesterol in treatment. Int Rev Psychiatry 20, 165-
170.  
 [200]  El Ansary A , Al Ayadhi L (2012) Lipid mediators in plasma of autism spectrum disorders. Lipids 
Health Dis 11, 160-  
 [201]  Pardo CA, Vargas DL, Zimmerman AW (2005) Immunity, neuroglia and neuroinflammation in autism. 
Int Rev Psychiatry 17, 485-495.  
 [202]  Wong CT, Wais J, Crawford DA (2015) Prenatal exposure to common environmental factors affects 
brain lipids and increases risk of developing autism spectrum disorders. Eur J Neurosci  
 [203]  Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP (2005) 
Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33, 195-
201.  
 [204]  Cipriani S, Mencarelli A, Chini MG, Distrutti E, Renga B, Bifulco G, Baldelli F, Donini A, Fiorucci S 
(2011) The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and 
immune response to experimental colitis. PLoS One 6, e25637-  
 [205]  de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, 
Francavilla R, Riegler G, Militerni R, Bravaccio C (2010) Alterations of the intestinal barrier 
in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr 
Gastroenterol Nutr 51, 418-424.  
75 
 
 [206]  Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R (2015) Clinical trials 
of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev 
55, 294-321.  
 [207]  McLay LL , France K (2016) Empirical research evaluating non-traditional approaches to managing 
sleep problems in children with autism. Dev Neurorehabil 19, 123-134.  
 [208]  Kaluzna-Czaplinska J, Socha E, Rynkowski J (2011) B vitamin supplementation reduces excretion of 
urinary dicarboxylic acids in autistic children. Nutr Res 31 , 497-502.  
 [209]  Mayr JA, Feichtinger RG, Tort F, Ribes A, Sperl W (2014) Lipoic acid biosynthesis defects. J Inherit 
Metab Dis 37, 553-563.  
 [210]  El Beshbishy HA, Aly HA, El Shafey M (2013) Lipoic acid mitigates bisphenol A-induced testicular 
mitochondrial toxicity in rats. Toxicol Ind Health 29, 875-887.  
 [211]  El Beshbishy HA, Mariah RA, Al Azhary NM, Aly HA, Ozbak HA, Baghdadi HH (2014) Influence of 
lipoic acid on testicular toxicity induced by bi-n-butyl phthalate in rats. Food Chem Toxicol  
71, 26-32.  
 [212]  Elshazly SM, El Moselhy MA, Barakat W (2014) Insights in the mechanism underlying the protective 
effect of alpha-lipoic acid against acetaminophen-hepatotoxicity. Eur J Pharmacol 726, 116-
123.  
 [213]  Jia L, Liu Z, Sun L, Miller SS, Ames BN, Cotman CW, Liu J (2007) Acrolein, a toxicant in cigarette 
smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by 
(R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci 48, 339-348.  
 [214]  Louhelainen M, Merasto S, Finckenberg P, Lapatto R, Cheng ZJ, Mervaala EM (2006) Lipoic acid 
supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in 
spontaneously hypertensive rats. J Hypertens 24, 947-956.  
 [215]  Kaplan KA, Odabasoglu F, Halici Z, Halici M, Cadirci E, Atalay F, Aydin O, Cakir A (2012) Alpha-
lipoic acid protects against indomethacin-induced gastric oxidative toxicity by modulating 
antioxidant system. J Food Sci 77, H224-H230.  
 [216]  Kim YS, Podder B, Song HY (2013) Cytoprotective effect of alpha-lipoic acid on paraquat-exposed 
human bronchial epithelial cells via activation of nuclear factor erythroid related factor-2 
pathway.  Biol Pharm Bull 36, 802-811.  
 [217]  Abdin AA , Sarhan NI (2011) Intervention of mitochondrial dysfunction-oxidative stress-dependent 
apoptosis as a possible neuroprotective mechanism of alpha-lipoic acid against rotenone-
induced parkinsonism and L-dopa toxicity. Neurosci Res 71, 387-395.  
 [218]  Mignini F, Nasuti C, Fedeli D, Mattioli L, Cosenza M, Artico M, Gabbianelli R (2013) Protective 
effect of alpha-lipoic acid on cypermethrin-induced oxidative stress in Wistar rats. Int J 
Immunopathol Pharmacol 26, 871-881.  
 [219]  Astiz M, de Alaniz MJ, Marra CA (2012) The oxidative damage and inflammation caused by pesticides 
are reverted by lipoic acid in rat brain. Neurochem Int 61, 1231-1241.  
 [220]  Mansoor S, Gupta N, Luczy-Bachman G, Limb GA, Kuppermann BD, Kenney MC (2013) Protective 
effects of lipoic acid on chrysene-induced toxicity on Muller cells in vitro. Mol Vis 19, 25-38.  
 [221]  Nagda G , Bhatt DK (2011) Alleviation of lindane induced toxicity in testis of Swiss mice (Mus 
musculus) by combined treatment with vitamin C, vitamin E and alpha-lipoic acid. Indian J 
Exp Biol 49, 191-199.  
76 
 
 [222]  Koga T, Ishida T, Takeda T, Ishii Y, Uchi H, Tsukimori K, Yamamoto M, Himeno M, Furue M, 
Yamada H (2012) Restoration of dioxin-induced damage to fetal steroidogenesis and 
gonadotropin formation by maternal co-treatment with alpha-lipoic acid. PLoS One 7, e40322-  
 [223]  Flora SJ, Shrivastava R, Mittal M (2013) Chemistry and pharmacological properties of some natural 
and synthetic antioxidants for heavy metal toxicity. Curr Med Chem 20, 4540-4574.  
 [224]  Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA (2012) Elevated fecal 
short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. 
Dig Dis Sci 57, 2096-2102.  
 [225]  Morris G, Berk M, Carvalho A, Caso JR, Sanz Y, Walder K, Maes M (2016) The Role of the Microbial 
Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the 
Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol  
 [226]  Mostafa GA , Al Ayadhi LY (2015) Reduced levels of plasma polyunsaturated fatty acids and serum 
carnitine in autistic children: relation to gastrointestinal manifestations. Behav Brain Funct 11, 
4-  
 [227]  Easton AS, Sarker MH, Fraser PA (1997) Two components of blood-brain barrier disruption in the rat. 
J Physiol 503 ( Pt 3), 613-623.  
 [228]  Braissant O, Cagnon L, Monnet-Tschudi F, Speer O, Wallimann T, Honegger P, Henry H (2008) 
Ammonium alters creatine transport and synthesis in a 3D culture of developing brain cells, 
resulting in secondary cerebral creatine deficiency. Eur J Neurosci  27, 1673-1685.  
 [229]  Lichtenberger LM , Romero JJ (1994) Effect of ammonium ion on the hydrophobic and barrier 
properties of the gastric mucus gel layer: implications on the role of ammonium in H. pylori-
induced gastritis. J Gastroenterol Hepatol 9 Suppl 1, S13-S19.  
 [230]  Lemberskiy-Kuzin L, Fainshtein M, Fridman P, Passwell E, Braiman A, Priel Z (2008) Localized 
cytosolic alkalization and its functional impact in ciliary cells. Biochim Biophys Acta 1783, 
1102-1110.  
 [231]  Bachmanov AA , Beauchamp GK (2007) Taste receptor genes. Annu Rev Nutr 27, 389-414.  
 [232]  Riera CE, Vogel H, Simon SA, le Coutre J (2007) Artificial sweeteners and salts producing a metallic 
taste sensation activate TRPV1 receptors. Am J Physiol Regul Integr Comp Physiol 293, 
R626-R634.  
 [233]  Green BG (2012) Chemesthesis and the chemical senses as components of a "chemofensor complex". 
Chem Senses 37, 201-206.  
 [234]  Lee RJ, Kofonow JM, Rosen PL, Siebert AP, Chen B, Doghramji L, Xiong G, Adappa ND, Palmer JN, 
Kennedy DW, Kreindler JL, Margolskee RF, Cohen NA (2014) Bitter and sweet taste 
receptors regulate human upper respiratory innate immunity. J Clin Invest 124, 1393-1405.  
 [235]  Palmnas MS, Cowan TE, Bomhof MR, Su J, Reimer RA, Vogel HJ, Hittel DS, Shearer J (2014) Low-
dose aspartame consumption differentially affects gut microbiota-host metabolic interactions 
in the diet-induced obese rat. PLoS One 9, e109841-  
 [236]  De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, 
Guerzoni ME, Gobbetti M, Francavilla R (2013) Fecal microbiota and metabolome of 
children with autism and pervasive developmental disorder not otherwise specified. PLoS One 
8, e76993-  
 [237]  Macfabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers 
M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: 
possible role of short chain fatty acids on the pathogenesis and characteristics of autism 
spectrum disorders. Behav Brain Res 176, 149-169.  
77 
 
 [238]  Shultz SR, Macfabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, Cain DP (2008) 
Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, 
impairs social behavior in the rat: implications for an animal model of autism. 
Neuropharmacology 54, 901-911.  
 [239]  Shultz SR, Macfabe DF, Martin S, Jackson J, Taylor R, Boon F, Ossenkopp KP, Cain DP (2009) 
Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid 
impair cognition and sensorimotor ability in the Long-Evans rat: further development of a 
rodent model of autism. Behav Brain Res 200 , 33-41.  
 [240]  Thomas RH, Meeking MM, Mepham JR, Tichenoff L, Possmayer F, Liu S, Macfabe DF (2012) The 
enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular 
species: further development of a rodent model of autism spectrum disorders. J 
Neuroinflammation 9, 153-  
 [241]  Warheit DB (2013) How to measure hazards/risks following exposures to nanoscale or pigment-grade 
titanium dioxide particles. Toxicol Lett 220, 193-204.  
 [242]  Wang H, Du LJ, Song ZM, Chen XX (2013) Progress in the characterization and safety evaluation of 
engineered inorganic nanomaterials in food. Nanomedicine (Lond) 8, 2007-2025.  
 [243]  Shi H, Magaye R, Castranova V, Zhao J (2013) Titanium dioxide nanoparticles: a review of current 
toxicological data. Part Fibre Toxicol 10, 15-  
 [244]  Valdiglesias V, Costa C, Sharma V, Kilic G, Pasaro E, Teixeira JP, Dhawan A, Laffon B (2013) 
Comparative study on effects of two different types of titanium dioxide nanoparticles on 
human neuronal cells. Food Chem Toxicol 57, 352-361.  
 [245]  Shukla RK, Sharma V, Pandey AK, Singh S, Sultana S, Dhawan A (2011) ROS-mediated genotoxicity 
induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol In Vitro 25, 231-
241.  
 [246]  Jo DH, Kim JH, Son JG, Song NW, Kim YI, Yu YS, Lee TG, Kim JH (2014) Anti-angiogenic effect of 
bare titanium dioxide nanoparticles on pathologic neovascularization without unbearable 
toxicity. Nanomedicine 10, 1109-1117.  
 [247]  Jo DH, Kim JH, Yu YS, Lee TG, Kim JH (2012) Antiangiogenic effect of silicate nanoparticle on 
retinal neovascularization induced by vascular endothelial growth factor. Nanomedicine 8, 
784-791.  
 [248]  Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, Yoshida T, Ogura T, 
Nabeshi H, Nagano K, Abe Y, Kamada H, Monobe Y, Imazawa T, Aoshima H, Shishido K, 
Kawai Y, Mayumi T, Tsunoda S, Itoh N, Yoshikawa T, Yanagihara I, Saito S, Tsutsumi Y 
(2011) Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat 
Nanotechnol 6, 321-328.  
 [249]  Shakeel M, Jabeen F, Shabbir S, Asghar MS, Khan MS, Chaudhry AS (2016) Toxicity of Nano-
Titanium Dioxide (TiO2-NP) Through Various Routes of Exposure: a Review. Biol Trace 
Elem Res 172, 1-36.  
 [250]  Takahashi Y, Mizuo K, Shinkai Y, Oshio S, Takeda K (2010) Prenatal exposure to titanium dioxide 
nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice. J 
Toxicol Sci 35, 749-756.  
 [251]  Shimizu M, Tainaka H, Oba T, Mizuo K, Umezawa M, Takeda K (2009) Maternal exposure to 
nanoparticulate titanium dioxide during the prenatal period alters gene expression related to 
brain development in the mouse. Part Fibre Toxicol 6, 20-  
 [252]  Xue Y, Wu J, Sun J (2012) Four types of inorganic nanoparticles stimulate the inflammatory reaction 
in brain microglia and damage neurons in vitro. Toxicol Lett 214, 91-98.  
78 
 
 [253]  Rihane N, Nury T, M'rad I, El Mir L, Sakly M, Amara S, Lizard G (2016) Microglial cells (BV-2) 
internalize titanium dioxide (TiO) nanoparticles: toxicity and cellular responses. Environ Sci 
Pollut Res Int  
 [254]  Lietz G, Oxley A, Boesch-Saadatmandi C, Kobayashi D (2012) Importance of beta,beta-carotene 
15,15'-monooxygenase 1 (BCMO1) and beta,beta-carotene 9',10'-dioxygenase 2 (BCDO2) in 
nutrition and health. Mol Nutr Food Res 56, 241-250.  
 [255]  Marsh RS, Yan Y, Reed VM, Hruszkewycz D, Curley RW, Harrison EH (2010) {beta}-
Apocarotenoids do not significantly activate retinoic acid receptors {alpha} or {beta}. Exp 
Biol Med (Maywood ) 235, 342-348.  
 [256]  Curley RW, Jr., Sundaram AK, Fowble JW, Abildgaard F, Westler WM, Markley JL (1999) NMR 
studies of retinoid-protein interactions: the conformation of [13C]-beta-ionones bound to beta-
lactoglobulin B. Pharm Res 16, 651-659.  
 [257]  Sima A, Parisotto M, Mader S, Bhat PV (2009) Kinetic characterization of recombinant mouse retinal 
dehydrogenase types 3 and 4 for retinal substrates. Biochim Biophys Acta 1790, 1660-1664.  
 [258]  Bagasra O, Golkar Z, Garcia M, Rice LN, Pace DG (2013) Role of perfumes in pathogenesis of autism. 
Med Hypotheses 80, 795-803.  
 [259]  Sealey LA, Hughes BW, Steinemann A, Pestaner JP, Gene PD, Bagasra O (2015) Environmental 
factors may contribute to autism development and male bias: Effects of fragrances on 
developing neurons. Environ Res 142, 731-738.  
 [260]  Darlenski R, Surber C, Fluhr JW (2010) Topical retinoids in the management of photodamaged skin: 
from theory to evidence-based practical approach. Br J Dermatol 163, 1157-1165.  
 [261]  Signorile A, Sardaro N, De Rasmo D, Scacco S, Papa F, Borracci P, Carratu MR, Papa S (2011) Rat 
embryo exposure to all-trans retinoic acid results in postnatal oxidative damage of respiratory 
complex I in the cerebellum. Mol Pharmacol 80 , 704-713.  
 [262]  Tomasova L, Hvizdosova N, Bolekova A, Smajda B, Kluchova D (2014) Vitamin A and amygdala: 
functional and morphological consequences. Neurol Sci 35, 1585-1589.  
 [263]  Coluccia A, Borracci P, Belfiore D, Renna G, Giustino A, Carratu MR (2008) Effects of early 
gestational all-trans retinoic acid treatment on motor skills: a longitudinal study in the 
offspring of Sprague-Dawley rats. Neurotoxicology 29, 1107-1113.  
 [264]  Coluccia A, Belfiore D, Bizzoca A, Borracci P, Trerotoli P, Gennarini G, Carratu MR (2008) 
Gestational all-trans retinoic acid treatment in the rat: neurofunctional changes and cerebellar 
phenotype. Neurotoxicol Teratol 30, 395-403.  
 [265]  Holson RR, Gazzara RA, Ferguson SA, Adams J (1997) Behavioral effects of low-dose gestational day 
11-13 retinoic acid exposure. Neurotoxicol Teratol 19, 355-362.  
 [266]  Danzer E, Schwarz U, Wehrli S, Radu A, Adzick NS, Flake AW (2005) Retinoic acid induced 
myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic 
resonance imaging. Exp Neurol 194, 467-475.  
 [267]  Jayarao M, Sohl K, Tanaka T (2015) Chiari malformation I and autism spectrum disorder: an 
underrecognized coexistence. J Neurosurg Pediatr 15, 96-100.  
 [268]  Allin MP (2016) Novel insights from quantitative imaging of the developing cerebellum. Semin Fetal 
Neonatal Med  
79 
 
 [269]  Stoodley CJ , Limperopoulos C (2016) Structure-function relationships in the developing cerebellum: 
Evidence from early-life cerebellar injury and neurodevelopmental disorders. Semin Fetal 
Neonatal Med  
 [270]  Crippa A, Del Vecchio G, Busti CS, Nobile M, Arrigoni F, Brambilla P (2016) Cortico-Cerebellar 
Connectivity in Autism Spectrum Disorder: What Do We Know So Far? Front Psychiatry 7, 
20-  
 [271]  Pan TL, Wang PW, Aljuffali IA, Huang CT, Lee CW, Fang JY (2015) The impact of urban particulate 
pollution on skin barrier function and the subsequent drug absorption. J Dermatol Sci 78, 51-
60.  
 [272]  Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ (1994) Characteristics of the inhibition of NADPH 
oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir 
Cell Mol Biol 11, 95-102.  
 [273]  Napoli E, Wong S, Hertz-Picciotto I, Giulivi C (2014) Deficits in Bioenergetics and Impaired Immune 
Response in Granulocytes From Children With Autism. Pediatrics  
 [274]  Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, Tassone F, Pessah 
IN (2010) Mitochondrial dysfunction in autism. JAMA 304, 2389-2396.  
 [275]  Jeong JB, Choi J, Lou Z, Jiang X, Lee SH (2013) Patchouli alcohol, an essential oil of Pogostemon 
cablin, exhibits anti-tumorigenic activity in human colorectal cancer cells. Int 
Immunopharmacol 16, 184-190.  
 [276]  Nelson ED, Bal M, Kavalali ET, Monteggia LM (2011) Selective impact of MeCP2 and associated 
histone deacetylases on the dynamics of evoked excitatory neurotransmission. J Neurophysiol 
106, 193-201.  
 [277]  Vecsler M, Simon AJ, Amariglio N, Rechavi G, Gak E (2010) MeCP2 deficiency downregulates 
specific nuclear proteins that could be partially recovered by valproic acid in vitro. 
Epigenetics 5, 61-67.  
 [278]  Gelb MH, Tamanoi F, Yokoyama K, Ghomashchi F, Esson K, Gould MN (1995) The inhibition of 
protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer 
Lett 91, 169-175.  
 [279]  Mijimolle N, Velasco J, Dubus P, Guerra C, Weinbaum CA, Casey PJ, Campuzano V, Barbacid M 
(2005) Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor 
development. Cancer Cell 7, 313-324.  
 [280]  Park HJ, Zhang Y, Georgescu SP, Johnson KL, Kong D, Galper JB (2006) Human umbilical vein 
endothelial cells and human dermal microvascular endothelial cells offer new insights into the 
relationship between lipid metabolism and angiogenesis. Stem Cell Rev 2, 93-102.  
 [281]  Gu WZ, Tahir SK, Wang YC, Zhang HC, Cherian SP, O'Connor S, Leal JA, Rosenberg SH, Ng SC 
(1999) Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in 
vitro and in vivo. Eur J Cancer 35, 1394-1401.  
 [282]  Miyazawa M, Shindo M, Shimada T (2002) Metabolism of (+)- and (-)-limonenes to respective 
carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug 
Metab Dispos 30, 602-607.  
 [283]  Yamazaki H , Shimada T (1997) Progesterone and testosterone hydroxylation by cytochromes P450 
2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 346, 161-169.  
 [284]  Raecker T, Thiele B, Boehme RM, Guenther K (2011) Endocrine disrupting nonyl- and octylphenol in 
infant food in Germany: considerable daily intake of nonylphenol for babies. Chemosphere  
82, 1533-1540.  
80 
 
 [285]  Guenther K, Heinke V, Thiele B, Kleist E, Prast H, Raecker T (2002) Endocrine disrupting 
nonylphenols are ubiquitous in food. Environ Sci Technol 36, 1676-1680.  
 [286]  Ademollo N, Ferrara F, Delise M, Fabietti F, Funari E (2008) Nonylphenol and octylphenol in human 
breast milk. Environ Int 34, 984-987.  
 [287]  Sakurai K , Mori C (2000) Fetal exposure to endocrine disruptors. Nihon Rinsho 58, 2508-2513.  
 [288]  Balbuena P, Li W, Ehrich M (2011) Assessments of tight junction proteins occludin, claudin 5 and 
scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: cellular 
responses to neurotoxicants malathion and lead acetate. Neurotoxicology 32, 58-67.  
 [289]  Sajja RK, Rahman S, Cucullo L (2016) Drugs of abuse and blood-brain barrier endothelial dysfunction: 
A focus on the role of oxidative stress. J Cereb Blood Flow Metab 36, 539-554.  
 [290]  Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L, 
Villarreal-Calderon R, Osnaya N, Stone I, Garcia R, Brooks DM, Gonzalez-Maciel A, 
Reynoso-Robles R, Delgado-Chavez R, Reed W (2008) Long-term air pollution exposure is 
associated with neuroinflammation, an altered innate immune response, disruption of the 
blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and 
alpha-synuclein in children and young adults. Toxicol Pathol 36, 289-310.  
 [291]  Calderon-Garciduenas L, Vojdani A, Blaurock-Busch E, Busch Y, Friedle A, Franco-Lira M, Sarathi-
Mukherjee P, Park SB, Torres-Jardon R, D'Angiulli A (2014) Air Pollution and Children: 
Neural and Tight Junction Antibodies and Combustion Metals, the Role of Barrier Breakdown 
and Brain Immunity in Neurodegeneration. J Alzheimers Dis  
 [292]  Menon PK, Muresanu DF, Sharma A, Mossler H, Sharma HS (2012) Cerebrolysin, a mixture of 
neurotrophic factors induces marked neuroprotection in spinal cord injury following 
intoxication of engineered nanoparticles from metals. CNS Neurol Disord Drug Targets 11, 
40-49.  
 [293]  Aufderheide M, Scheffler S, Ito S, Ishikawa S, Emura M (2015) Ciliatoxicity in human primary 
bronchiolar epithelial cells after repeated exposure at the air-liquid interface with native 
mainstream smoke of K3R4F cigarettes with and without charcoal filter. Exp Toxicol Pathol 
67, 407-411.  
 [294]  Astrand AB, Hemmerling M, Root J, Wingren C, Pesic J, Johansson E, Garland AL, Ghosh A, Tarran 
R (2015) Linking increased airway hydration, ciliary beating, and mucociliary clearance 
through ENaC inhibition. Am J Physiol Lung Cell Mol Physiol 308, L22-L32.  
 [295]  Wyatt TA, Sisson JH, Allen-Gipson DS, McCaskill ML, Boten JA, DeVasure JM, Bailey KL, Poole JA 
(2012) Co-exposure to cigarette smoke and alcohol decreases airway epithelial cell cilia 
beating in a protein kinase Cepsilon-dependent manner. Am J Pathol 181, 431-440.  
 [296]  Mallants R, Vlaeminck V, Jorissen M, Augustijns P (2009) An improved primary human nasal cell 
culture for the simultaneous determination of transepithelial transport and ciliary beat 
frequency. J Pharm Pharmacol 61, 883-890.  
 [297]  Erdogan S, Zeren EH, Emre M, Aydin O, Gumurdulu D (2006) Pulmonary effects of deltamethrin 
inhalation: an experimental study in rats. Ecotoxicol Environ Saf 63, 318-323.  
 [298]  Kucera SP, Swann JM, Kennedy JR, Schultz TW (1995) The effects of benomyl and its breakdown 
products carbendazim and butyl isocyanate on the structure and function of tracheal ciliated 
cells. J Environ Sci Health B 30, 779-799.  
 [299]  Jain R, Ray JM, Pan JH, Brody SL (2012) Sex hormone-dependent regulation of cilia beat frequency in 
airway epithelium. Am J Respir Cell Mol Biol 46, 446-453.  
81 
 
 [300]  Schiff LJ , Graham JA (1984) Cytotoxic effect of vanadium and oil-fired fly ash on hamster tracheal 
epithelium. Environ Res 34, 390-402.  
 [301]  Gabridge MG, Dougherty EP, Gladd MF, Meccoli RA (1982) Effects of heavy metals on structure, 
function, and metabolism of ciliated respiratory epithelium in vitro. In Vitro 18, 1023-1032.  
 [302]  Vecchiato M, Cremonese S, Gregoris E, Barbaro E, Gambaro A, Barbante C (2016) Fragrances as new 
contaminants in the Venice lagoon. Sci Total Environ 566-567, 1362-1367.  
 [303]  Avar P, Maasz G, Takacs P, Lovas S, Zrinyi Z, Svigruha R, Takatsy A, Toth LG, Pirger Z (2016) 
HPLC-MS/MS analysis of steroid hormones in environmental water samples. Drug Test Anal 
8, 123-127.  
 [304]  Ruhi A, Acuna V, Barcelo D, Huerta B, Mor JR, Rodriguez-Mozaz S, Sabater S (2016) 
Bioaccumulation and trophic magnification of pharmaceuticals and endocrine disruptors in a 
Mediterranean river food web. Sci Total Environ 540, 250-259.  
 [305]  Brar NK, Waggoner C, Reyes JA, Fairey R, Kelley KM (2010) Evidence for thyroid endocrine 
disruption in wild fish in San Francisco Bay, California, USA. Relationships to contaminant 
exposures. Aquat Toxicol 96, 203-215.  
 [306]  Lyons R, Van de BK, Morgan-Jones S (2014) Deposition patterns and transport mechanisms for the 
endocrine disruptor 4-nonylphenol across the Sierra Nevada Mountains, California. Environ 
Pollut 195, 123-132.  
 [307]  Woodruff TJ, Zota AR, Schwartz JM (2011) Environmental chemicals in pregnant women in the 
United States: NHANES 2003-2004. Environ Health Perspect 119, 878-885.  
 [308]  Bennett D, Bellinger DC, Birnbaum LS, Bradman A, Chen A, Cory-Slechta DA, Engel SM, Fallin MD, 
Halladay A, Hauser R, Hertz-Picciotto I, Kwiatkowski CF, Lanphear BP, Marquez E, Marty 
M, McPartland J, Newschaffer CJ, Payne-Sturges D, Patisaul HB, Perera FP, Ritz B, Sass J, 
Schantz SL, Webster TF, Whyatt RM, Woodruff TJ, Zoeller RT, Anderko L, Campbell C, 
Conry JA, DeNicola N, Gould RM, Hirtz D, Huffling K, Landrigan PJ, Lavin A, Miller M, 
Mitchell MA, Rubin L, Schettler T, Tran HL, Acosta A, Brody C, Miller E, Miller P, Swanson 
M, Witherspoon NO (2016) Project TENDR: Targeting Environmental Neuro-Developmental 
Risks. The TENDR Consensus Statement. Environ Health Perspect 124, A118-A122.  
 [309]  Lam J, Sutton P, Kalkbrenner A, Windham G, Halladay A, Koustas E, Lawler C, Davidson L, Daniels 
N, Newschaffer C, Woodruff T (2016) A Systematic Review and Meta-Analysis of Multiple 
Airborne Pollutants and Autism Spectrum Disorder. PLoS One 11, e0161851-  
 [310]  Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K (2016) Prenatal selective serotonin reuptake inhibitor 
use and the risk of autism spectrum disorder in children: A systematic review and meta-
analysis. Reprod Toxicol 66, 31-43.  
 [311]  Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F (2016) Serum concentration of 25-
hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur 
Child Adolesc Psychiatry 25, 341-350.  
 [312]  Jeddi MZ, Janani L, Memari AH, Akhondzadeh S, Yunesian M (2016) The role of phthalate esters in 
autism development: A systematic review. Environ Res 151, 493-504.  
 [313]  Kettlewell HBD (1955) Selection experiments on industrial melanism in the Lepidoptera. Heredity 9, 
323-342. 
 [314]  Grant BS , Wiseman LL (2002) Recent history of melanism in American peppered moths. J Hered 93, 
86-90.  
 
